Pabst, Thomas

{"headers":{"title":"Title","year":"Year","type":"Type"},"rows":[{"title":"Rausch, C., Bacher, U., Rabaglio, M., Vorburger, C., Klingenberg, A., Banz, Y., Daskalakis, M., \u0026 Pabst, T. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/221838\u0022\u003ERandomized Phase II Study of Brentuximab-Vedotin With High-Dose Chemotherapy in CD30 Positive Lymphoma\u003C\/a\u003E. \u003Ci\u003EHematological Oncology\u003C\/i\u003E, \u003Ci\u003E43\u003C\/i\u003E(6), e70143.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Magno, G., Rejeski, K., Rappa, G., Stock, S., Holzem, A., Landwehr, M., Seib, M., Kutsch, N., Mammadova, J., Mayer, S., Aumann, S., Van Ham, J., Ringelstein-Harlev, S., Velazquez, G. F., Wurm-Kuczera, R., Scholz, J. K., Greenbaum, U., Raj, S. S., Shouval, R., \u2026 Subklewe, M. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/221818\u0022\u003EPrognostic Value of Inflammation-Based Scores in R\/R LBCL Patients Treated with CD3xCD20 Bispecific T-Cell Engagers\u003C\/a\u003E. \u003Ci\u003EBlood Advances\u003C\/i\u003E.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Seipel, K., Spahr, S., Bacher, U., Shaforostova, I., Nilius, H., \u0026 Pabst, T. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/222262\u0022\u003EClinical Impact of LAG3 Single-Nucleotide Polymorphism in DLBCL Treated with CAR-T Cell Therapy\u003C\/a\u003E. \u003Ci\u003EInternational Journal of Molecular Sciences\u003C\/i\u003E, \u003Ci\u003E26\u003C\/i\u003E(20).","year":2025,"type":"Journal Article (Original Article)"},{"title":"Mocking, T. R., Haaksma, L. H., Reuvekamp, T., Kelder, A., Scholten, W. J., Ngai, L. L., Breems, D. A., Fischer, T., Gjertsen, B. T., Gri\u0161kevi\u010dius, L., Juliusson, G., Maertens, J. A., Manz, M. G., Pabst, T., Passweg, J. R., Porkka, K., Valk, P. J. M., Gradowska, P., L\u00f6wenberg, B., \u2026 Bachas, C. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/218164\u0022\u003EComputational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial\u003C\/a\u003E. \u003Ci\u003ELeukemia\u003C\/i\u003E, \u003Ci\u003E39\u003C\/i\u003E, 2559-2562.","year":2025,"type":"Journal Article (Further Contribution)"},{"title":"Rausch, C., Bacher, U., Tchinda, J., Hoffmann, M., Seipel, K., \u0026 Pabst, T. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/219225\u0022\u003EObservation of PICALM::MLLT10-rearrangement and coincidental EZH2 mutations in a patient with acute myeloid leukemia: A case report and review of the literature\u003C\/a\u003E. \u003Ci\u003EBJC Reports\u003C\/i\u003E, \u003Ci\u003E3\u003C\/i\u003E(1), 66.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Darphin, X., Blattner, J., Hoffmann, M., Gobat, K., Kronig, M.-N., Pabst, T., \u0026 \u00d6zdemir, B. C. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/219326\u0022\u003ESex-Associated Differences in Outcomes in Acute Myeloid Leukemia Patients Following Intense Induction Treatment: A Real-World Single Center Analysis\u003C\/a\u003E. \u003Ci\u003EJournal of Clinical Medicine\u003C\/i\u003E, \u003Ci\u003E14\u003C\/i\u003E(18).","year":2025,"type":"Journal Article (Original Article)"},{"title":"Sch\u00fcrch, S., Dr\u00e4ger, S., Hoffmann, M., Bausch, S., G\u00fcrtler, N., Hirzel, C., Passweg, J., Bassetti, S., Pabst, T., Sendi, P., \u0026 Osthoff, M. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/219329\u0022\u003EIncidence of Acute Kidney Injury in Autologous Hematopoietic Stem Cell Transplant Recipients According to the Administration of Empirical Amikacin: A Two-Centre Retrospective Cohort Study\u003C\/a\u003E. \u003Ci\u003EAntibiotics\u003C\/i\u003E, \u003Ci\u003E14\u003C\/i\u003E(9).","year":2025,"type":"Journal Article (Original Article)"},{"title":"Jutzi, J. T., Wampfler, J., Ionescu, C., Kronig, M., Jeker, B., Hoffmann, M., Reusser, I., Haslebacher, C., Sendi Stamm, S., Schletti, M., L\u00fcscher, B. P., Bacher, V., Wehrli, M., Daskalakis, M., Pabst, T., \u0026 Novak, U. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/217543\u0022\u003ECAR T-Cell Therapies for Patients With Relapsed and Refractory Aggressive Lymphomas: Real-World Experiences From a Single Center on the Use of Radiotherapy\u003C\/a\u003E. \u003Ci\u003EHematological Oncology\u003C\/i\u003E, \u003Ci\u003E43\u003C\/i\u003E(5), e70124.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Schmid, C., Sponagel, K., Bacher, U., Seipel, K., Porret, N., Wiedemann, G., Hoffmann, M., Daskalakis, M., \u0026 Pabst, T. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/217564\u0022\u003EClonal Hematopoiesis and Outcomes After High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with AML, Myeloma, and Lymphoma\u003C\/a\u003E. \u003Ci\u003EInternational Journal of Molecular Sciences\u003C\/i\u003E, \u003Ci\u003E26\u003C\/i\u003E(16).","year":2025,"type":"Journal Article (Original Article)"},{"title":"Shumilov, E., Scholz, J. K., Seib, M., Mazzeo, P., Wurm-Kuczera, R., Vucinic, V., Holtick, U., Boyadzhiev, H., Melchardt, T., H\u00f6lscher, A. S., Schultze-Florey, C. R., Abdelhafez, A., Velazquez, G. F., Ossami Saidy, A., Lesan, V., Schnetzke, U., Kerkhoff, A., Bacher, U., Ghandili, S., \u2026 Lenz, G. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/210156\u0022\u003EOutcomes of bispecific antibody therapy after CAR T-cell failure in relapsed\/refractory large B-cell lymphoma\u003C\/a\u003E. \u003Ci\u003EBlood Advances\u003C\/i\u003E, \u003Ci\u003E9\u003C\/i\u003E, 3955-3966.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Shumilov, E., Wurm-Kuczera, R., Kerkhoff, A., Wang, M., Melchardt, T., Holtick, U., Bacher, U., Staber, P. B., Mazzeo, P., Leng, C., B\u00f6ckle, D., H\u00f6lscher, A. S., Kauer, J., Rotter, N., Vucinic, V., Rudzki, J. D., Nachbaur, D., B\u00fccklein, V. L., Schnetzke, U., \u2026 Chapuy, B. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/194513\u0022\u003ESafety and Efficacy of Glofitamab for Relapsed\/Refractory Large B-Cell Lymphoma in a Multinational Real-World Study\u003C\/a\u003E. \u003Ci\u003EBlood Advances\u003C\/i\u003E, \u003Ci\u003E9\u003C\/i\u003E, 3865-3877.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Burger, A., Bacher, U., Hoffmann, M., Seipel, K., Schild, C., Shaforostova, I., \u0026 Pabst, T. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/217392\u0022\u003ESerum Immunoglobulin Changes in Multiple Myeloma Patients Treated with CAR T-Cell Therapy\u003C\/a\u003E. \u003Ci\u003ECurrent Issues in Molecular Biology\u003C\/i\u003E, \u003Ci\u003E47\u003C\/i\u003E(8).","year":2025,"type":"Journal Article (Original Article)"},{"title":"Maulhardt, M., Call, S., Boyadzhiev, H., Albici, A. M., H\u00f6rster, K., Boquoi, A., Janjetovic, S., Ossami Saidy, A., Teichert, M., Brioli, A., Schultze-Florey, C., Heidel, F., Schindler, P., Schub, N., Aydilek, E., Stelljes, M., Daskalakis, M., Krekeler, C., Hasenkamp, J., \u2026 Shumilov, E. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/215152\u0022\u003EEfficacy of idecabtagene vicleucel in patients with relapsed\/refractory multiple myeloma and prior central nervous system manifestation: A multicenter real-world analysis\u003C\/a\u003E. \u003Ci\u003EHemaSphere\u003C\/i\u003E, \u003Ci\u003E9\u003C\/i\u003E(8), e70192.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Zeidner, J. F., Sallman, D. A., R\u00e9cher, C., Daver, N. G., Leung, A. Y., Hiwase, D. K., Subklewe, M., Pabst, T., Montesinos, P., Larson, R. A., Wilde, L., Enjeti, A. K., Kawashima, I., Papayannidis, C., O\u2019Nions, J., Johnson, L., Dong, M., Huang, J., Bagheri, T., \u2026 Vyas, P. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/206106\u0022\u003EMagrolimab plus azacitidine vs physician\u2019s choice for untreated TP53-mutated acute myeloid leukemia: the ENHANCE-2 study\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E146\u003C\/i\u003E, 590-600.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Seipel, K., Shaforostova, I., Nilius, H., Bacher, U., \u0026 Pabst, T. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/217610\u0022\u003EClinical Impact of CTLA-4 Single-Nucleotide Polymorphism in DLBCL Patients Treated with CAR-T Cell Therapy\u003C\/a\u003E. \u003Ci\u003ECurrent Oncology\u003C\/i\u003E, \u003Ci\u003E32\u003C\/i\u003E(8).","year":2025,"type":"Journal Article (Original Article)"},{"title":"Rieger, M. J., Flammer, A. J., Gerull, S., Pabst, T., Auner, H. W., Samii, K., Hitz, F., Mey, U., Ballova, V., Battegay, R., Melli, G., Benz, D., Yakupoglu, Y., Gr\u00e4ni, C., Schl\u00e4ger, R., Hugelshofer, S., Studer, A., Oechslin, L., Bakula, A., \u2026 Schwotzer, R. (2025). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/214843\u0022\u003EUpdated recommendations for the treatment of light-chain amyloidosis from the Swiss Amyloidosis Network.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003ESwiss Medical Weekly\u003C\/i\u003E, \u003Ci\u003E155\u003C\/i\u003E, 4219.","year":2025,"type":"Journal Article (Review)"},{"title":"Hoffmann, M., Jeker, B., Huynh-Do, U., Banz, Y., Godau, J., Weber, E., Bacher, U., \u0026 Pabst, T. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/213502\u0022\u003EElranatamab for Relapsed\/Refractory Multiple Myeloma With Severe Renal Impairment Requiring Hemodialysis\u003C\/a\u003E. \u003Ci\u003EHematological Oncology\u003C\/i\u003E, \u003Ci\u003E43\u003C\/i\u003E(4), e70120.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Hermans, S. J. F., Versluis, J., van Werkhoven, E. D., van Norden, Y., Janssen, J. J. W. M., Huls, G. A., Pabst, T., Breems, D. A., Berkx, E., Dinmohamed, A. G., Huijgens, P. C., Str\u00e4ng, E., Hern\u00e1ndez Rivas, J. M., Sobas, M., Ayala Diaz, R., Martinez Lopez, J., Metzeler, K. H., Haferlach, T., Thiede, C., \u2026 Cornelissen, J. J. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/211697\u0022\u003EComparability of external and internal control patients for the prospective randomized HOVON-103 trial in older AML patients\u003C\/a\u003E. \u003Ci\u003EBritish Journal of Haematology\u003C\/i\u003E.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Venditti, A., Palmieri, R., Maurillo, L., R\u00f6llig, C., Wierzbowska, A., de Leeuw, D. C., Efficace, F., Curti, A., Ngai, L. L., Tettero, J. M., Ad\u00e8s, L., Almeida, A. M., Bullinger, L., Dennis, M., Esteve, J., Ferrara, F., Heuser, M., Huls, G. A., L\u00fcbbert, M., \u2026 Ossenkoppele, G. J. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/205102\u0022\u003EFITNESS ASSESSMENT IN ACUTE MYELOID LEUKEMIA: RECOMMENDATIONS FROM AN EXPERT PANEL ON BEHALF OF EUROPEAN LEUKEMIA NET\u003C\/a\u003E. \u003Ci\u003EBlood Advances\u003C\/i\u003E, \u003Ci\u003E9\u003C\/i\u003E(9), 2207-2220.","year":2025,"type":"Journal Article (Original Article)"},{"title":"K\u00fcndgen, L. J., Akhoundova, D., Hoffmann, M., Legros, M., Shaforostova, I. I., Seipel, K., Bacher, U., \u0026 Pabst, T. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/211196\u0022\u003EPrognostic Value of Post-Transplant MRD Negativity in Standard Versus High- and Ultra-High-Risk Multiple Myeloma Patients\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E17\u003C\/i\u003E(9).","year":2025,"type":"Journal Article (Original Article)"},{"title":"Ngai, L. L., Reuvekamp, T., Hanekamp, D., Janssen, F., Marsbergen, L. O.- van, Carbaat-Ham, J., Hofland, M. A. M., Fayed, M. M. H. E., Kelder, A., Scholten, W. J., Snel, A. N., Bachas, C., Tettero, J. M., Breems, D. A., Fischer, T., Gjertsen, B. T., Gri\u0161kevi\u010dius, L., Juliusson, G., Van de Loosdrecht, A. A., \u2026 Cloos, J. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/210726\u0022\u003EDifferent features of acute myeloid leukemia stem cell quantification in intensively treated patients\u003C\/a\u003E. \u003Ci\u003EHaematologica\u003C\/i\u003E.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Gennheimer, V., Akhoundova, D., Hoffmann, M., Jeker, B., Banz, Y., Bacher, U., \u0026 Pabst, T. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/210201\u0022\u003EAdherence to Multidisciplinary Tumor Board Recommendations in Patients with Multiple Myeloma\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E17\u003C\/i\u003E(8).","year":2025,"type":"Journal Article (Original Article)"},{"title":"Reuvekamp, T., Ngai, L. L., den Hartog, D., Carbaat-Ham, J., Fayed, M. M. H. E., Scholten, W. J., Mocking, T. R., Chitu, D. A., Pabst, T., Klein, S. K., Stussi, G., Griskevicius, L., Breems, D., van Lammeren-Venema, D., Boersma, R., Ossenkoppele, G. J., van de Loosdrecht, A. A., Bachas, C., Huls, G., \u2026 Cloos, J. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/206085\u0022\u003ECD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents\u003C\/a\u003E. \u003Ci\u003ELeukemia\u003C\/i\u003E, \u003Ci\u003E39\u003C\/i\u003E(4), 972-975.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Sch\u00fcpbach, A., Akhoundova, D., Bacher, U., Nilius, H., Hoffmann, M., Largiad\u00e8r, C. R., Aebi, Y., Hayoz, M., Kronig, M.-N., \u0026 Pabst, T. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/209740\u0022\u003EImpact of Venetoclax Treatment Schedule on Hematologic Recovery and Treatment Response in AML Patients Unfit for Intensive Chemotherapy\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E17\u003C\/i\u003E(7).","year":2025,"type":"Journal Article (Original Article)"},{"title":"Jeker, B., Thalmann, L., Bacher, U., Nilius, H., Rhyner, G., S\u00f6kler, M., Soltermann, S., Winkler, A., Vorburger, C., Daskalakis, M., Hoffmann, M., \u0026 Pabst, T. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/190636\u0022\u003EComparing stem cell mobilization with chemotherapy and cytokine (G-CSF) versus cytokine alone in myeloma patients (MOCCCA): a randomized phase II, open-label, non-inferiority trial\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E60\u003C\/i\u003E(3), 270-276.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Meier-Lienhard, R., Suter, C., Pabst, T., Hitz, F., Passweg, J. R., Spertini, O., Cantoni, N., Betticher, D., Simeon, L., Medinger, M., Hayoz, S., \u0026 Schmidt, A. (2025). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/204566\u0022\u003EBlastic plasmacytoid dendritic cell neoplasm: a Swiss case series of a very rare disease and a structured review of the literature.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003ESwiss Medical Weekly\u003C\/i\u003E, \u003Ci\u003E155\u003C\/i\u003E(1), 3885.","year":2025,"type":"Journal Article (Review)"},{"title":"Kielkopf, M. C., G\u00f6cmen, J., Venzin, S. B., Steinauer, F., Branca, M., Boronylo, A., G\u00f6ldlin, M. B., Kaesmacher, J., Mujanovic, A., Costamagna, G., Meinel, T. R., Seiffge, D. J., B\u00fccke, P., Heldner, M. R., Liberman, A. L., Kamel, H., Fischer, U., Arnold, M., Pabst, T., \u2026 Beyeler, M. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/219693\u0022\u003EAnticoagulant versus antiplatelet treatment for secondary stroke prevention in patients with active cancer\u003C\/a\u003E. \u003Ci\u003EFrontiers in Neurology\u003C\/i\u003E, \u003Ci\u003E16\u003C\/i\u003E, 1530775.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Merz, M., Albici, A.-M., von Tresckow, B., Rathje, K., Fenk, R., Holderried, T., M\u00fcller, F., Tovar, N., Oliver-C\u00e1ldes, A., Vucinic, V., Kharboutli, S., B\u00e4rmann, B.-N., Ayuk, F., Platzbecker, U., St\u00f6lzel, F., Schub, N., Schmitz, F., Fandrei, D., Born, P., \u2026 Gagelmann, N. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/203538\u0022\u003EIdecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study\u003C\/a\u003E. \u003Ci\u003EHemaSphere\u003C\/i\u003E, \u003Ci\u003E9\u003C\/i\u003E(1), e70070.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Merz, M., Dima, D., Hashmi, H., Ahmed, N., St\u00f6lzel, F., Holderried, T. A. W., Fenk, R., M\u00fcller, F., Tovar, N., Oliver-C\u00e1ldes, A., Rathje, K., Davis, J. A., Fandrei, D., Vucinic, V., Kharboutli, S., Baermann, B.-N., Ayuk, F., Platzbecker, U., Albici, A.-M., \u2026 Gagelmann, N. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/194322\u0022\u003EBispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy\u003C\/a\u003E. \u003Ci\u003EBlood Cancer Journal\u003C\/i\u003E, \u003Ci\u003E14\u003C\/i\u003E(1), 214.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Ailawadhi, S., Arnulf, B., Patel, K. K., Cavo, M., Nooka, A. K., Manier, S., Callander, N. S., Costa, L. J., Vij, R., Bahlis, N. J., Moreau, P., Solomon, S. R., Abrahamsen, I. W., Baz, R. C., Broijl, A., Chen, C., Jagannath, S., Raje, N., Scheid, C., \u2026 Rodriguez-Otero, P. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/44745\u0022\u003EIde-cel vs standard regimens in triple-class-exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analyses\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E144\u003C\/i\u003E(23).","year":2024,"type":"Journal Article (Original Article)"},{"title":"Beyeler, M., Pawar, A., Buffle, E., Zhang, C., Liao, V., Liberman, A. L., Pabst, T., Berger, M. D., Jung, S., Kamel, H., \u0026 Navi, B. B. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/125211\u0022\u003ECancer and left atrial enlargement in patients with ischemic stroke\u003C\/a\u003E. \u003Ci\u003EJournal of Stroke \u0026 Cerebrovascular Diseases\u003C\/i\u003E, \u003Ci\u003E33\u003C\/i\u003E(12), 108045.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Pabst, T., \u0026 Maurer, B. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/194371\u0022\u003ETherapies for systemic lupus erythematosus\u003C\/a\u003E. \u003Ci\u003EThe Lancet\u003C\/i\u003E, \u003Ci\u003E404\u003C\/i\u003E(10468), 2162.","year":2024,"type":"Journal Article (Further Contribution)"},{"title":"Bacher, U., \u0026 Pabst, T. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/188818\u0022\u003EBridging radiotherapy before CAR-T therapy in CNS lymphoma\u003C\/a\u003E. \u003Ci\u003EBlood Advances\u003C\/i\u003E, \u003Ci\u003E8\u003C\/i\u003E(19), 5190-5191.","year":2024,"type":"Journal Article (Further Contribution)"},{"title":"Arber, C., Baerlocher, G., Chalandon, Y., Daskalakis, M., Duchosal, M., Fehr, M., Gerull, S., G\u00fcng\u00f6r, T., Nair, G., Pabst, T., Passweg, J. R., Piccolruaz, B., Renner, C., Ruefer, A., Schneidawind, D., St\u00fcssi, G., Zeerleder, S., \u0026 Halter, J. P. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/188821\u0022\u003ETechnical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data\u003C\/a\u003E. \u003Ci\u003ESwiss Medical Weekly\u003C\/i\u003E, \u003Ci\u003E154\u003C\/i\u003E(10), 3704.","year":2024,"type":"Journal Article (Further Contribution)"},{"title":"Al Hamed, R., Labopin, M., Wu, D., Gedde-Dahl, T., Aljurf, M., Forcade, E., Salmenniemi, U., Passweg, J., Maertens, J., Pabst, T. N., Versluis, J., It\u00e4la-Remes, M., Huang, X.-J., Van Gorkom, G., Schroeder, T., Sanz, J., Blaise, D., Rem\u00e9nyi, P., Schanz, U., \u2026 Mohty, M. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/179552\u0022\u003EAllogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in first complete remission: data from the EBMT\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E59\u003C\/i\u003E(10), 1458-1465.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Steinauer, F., B\u00fccke, P. J., Buffle, E. J., Branca, M., G\u00f6cmen, J., Navi, B. B., Liberman, A., Boronylo, A., Cl\u00e9nin, L. C., G\u00f6ldlin, M. B., Lippert, J. P., Volbers, B., Meinel, T. R., Seiffge, D. J., Mujanovi\u0107, A., Kaesmacher, J., Fischer, U. M., Arnold, M., Pabst, T. N., \u2026 Beyeler, M. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/177815\u0022\u003EPrevalence of right-left shunt in stroke patients with cancer\u003C\/a\u003E. \u003Ci\u003EInternational Journal of Stroke\u003C\/i\u003E, \u003Ci\u003E19\u003C\/i\u003E(9), 1020-1027.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Kartal-Kaess, M., Karow, A., Bacher, V. U., Pabst, T. N., Joncourt, R., Zweier, C. G., K\u00fchni, C., Porret, N., \u0026 R\u00f6ssler, J. K. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/178020\u0022\u003EClonal hematopoiesis of indeterminate potential is rare in pediatric patients undergoing autologous stem cell transplantation\u003C\/a\u003E. \u003Ci\u003EPediatric Hematology and Oncology\u003C\/i\u003E, \u003Ci\u003E41\u003C\/i\u003E(7), 530-539.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Heini, A., Kammermann, K., Bacher, U., Jeker, B., Hayoz, M., Aebi, Y., Largiad\u00e8r, C. R., Nilius, H., \u0026 Pabst, T. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/188819\u0022\u003EGender-Specific Prognostic Impact of Treosulfan Levels in High-Dose Chemotherapy for Multiple Myeloma\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E16\u003C\/i\u003E(19).","year":2024,"type":"Journal Article (Original Article)"},{"title":"G\u00f6cmen, J., Steinauer, F., Kielkopf, M. C., Branca, M., Kurmann, C. C., Cl\u00e9nin, L. C., Mujanovi\u0107, A., Silimon, N., Boronylo, A., Scutelnic, A., Meinel, T. R., Kaesmacher, J., B\u00fccke, P. J., Seiffge, J. D., Costamagna, G., Michel, P., Fischer, U. M., Arnold, M., Navi, B. B., \u2026 Beyeler, M. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/179617\u0022\u003EMortality in acute ischemic stroke patients with new cancer diagnosed during the index hospitalization versus after discharge\u003C\/a\u003E. \u003Ci\u003EJournal of Stroke and Cerebrovascular Diseases\u003C\/i\u003E, \u003Ci\u003E33\u003C\/i\u003E(10), 107899.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Rieger, M. J., Pabst, T. N., Jeker, B., Paul, P., Bergamini, F., B\u00fchler, M. M., Condoluci, A., Flammer, A. J., Rossi, D., Stussi, G., Gerber, B., \u0026 Schwotzer, R. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/179220\u0022\u003EThree years follow-up of Venetoclax in advanced-stage, relapsed or refractory AL amyloidosis with cardiac involvement and t(11;14) with BCL2 expression\u003C\/a\u003E. \u003Ci\u003EAnnals of Hematology\u003C\/i\u003E, \u003Ci\u003E103\u003C\/i\u003E(10), 4163-4170.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Pabst, T. N., \u0026 Bacher, V. U. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/179791\u0022\u003EBoosting CAR T cells against lymphomas\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E144\u003C\/i\u003E(7), 689-691.","year":2024,"type":"Journal Article (Further Contribution)"},{"title":"Wiedemann, G., Bacher, U., Joncourt, R., Solly, F., Widmer, C. C., Zeerleder, S., Novak, U., Pabst, T., \u0026 Porret, N. A. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/44732\u0022\u003EA Comprehensive ddPCR Strategy for Sensitive and Reliable Monitoring of CAR-T Cell Kinetics in Clinical Applications\u003C\/a\u003E. \u003Ci\u003EInternational Journal of Molecular Sciences\u003C\/i\u003E, \u003Ci\u003E25\u003C\/i\u003E(16).","year":2024,"type":"Journal Article (Original Article)"},{"title":"Seipel, K., Veglio, N., Nilius, H., Jeker, B., Bacher, U., \u0026 Pabst, T. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/44756\u0022\u003ERising Prevalence of Low-Frequency PPM1D Gene Mutations after Second HDCT in Multiple Myeloma\u003C\/a\u003E. \u003Ci\u003ECurrent Issues in Molecular Biology\u003C\/i\u003E, \u003Ci\u003E46\u003C\/i\u003E(8).","year":2024,"type":"Journal Article (Original Article)"},{"title":"Ay\u00e7i\u00e7ek, S. G., Akhoundova Sanoyan, D., Bacher, V. U., Hayoz, M., Aebi, Y., Largiad\u00e8r, C. R., \u0026 Pabst, T. N. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/179677\u0022\u003EDeterminants of Interpatient Variability in Treosulfan Pharmacokinetics in AML Patients Undergoing Autologous Stem Cell Transplantation\u003C\/a\u003E. \u003Ci\u003EInternational Journal of Molecular Sciences\u003C\/i\u003E, \u003Ci\u003E25\u003C\/i\u003E(15).","year":2024,"type":"Journal Article (Original Article)"},{"title":"Martinez Flores, D., Akhoundova Sanoyan, D., Seipel, K., Legros, M., Kronig, M.-N., Daskalakis, M., Bacher, V. U., \u0026 Pabst, T. N. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/179435\u0022\u003EGemtuzumab Ozogamicin and Stem Cell Mobilization for Autologous Stem Cell Transplantation in Favorable Risk Acute Myeloid Leukemia\u003C\/a\u003E. \u003Ci\u003EBiomedicines\u003C\/i\u003E, \u003Ci\u003E12\u003C\/i\u003E(7).","year":2024,"type":"Journal Article (Original Article)"},{"title":"Eggimann, M., Akhoundova Sanoyan, D., Nilius, H. J. J., Hoffmann, M., Hayoz, M., Aebi, Y., Largiad\u00e8r, C. R., Daskalakis, M., Bacher, V. U., \u0026 Pabst, T. N. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/177654\u0022\u003ESafety and Efficacy of High-Dose Chemotherapy with TreoMel 200 vs. TreoMel 140 in Acute Myeloid Leukemia Patients Undergoing Autologous Stem Cell Transplantation\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E16\u003C\/i\u003E(10).","year":2024,"type":"Journal Article (Original Article)"},{"title":"Mehl, J., Akhoundova Sanoyan, D., Bacher, V. U., Jeker, B., Rhyner Agocs, G., Ruefer, A., Soltermann, S., Soekler, M., Winkler, A., Daskalakis, M., \u0026 Pabst, T. N. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/177655\u0022\u003EDaratumumab during Myeloma Induction Therapy Is Associated with Impaired Stem Cell Mobilization and Prolonged Post-Transplant Hematologic Recovery\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E16\u003C\/i\u003E(10).","year":2024,"type":"Journal Article (Original Article)"},{"title":"Aydilek, E., Wulf, G., Schwarz, F., Bacher, V. U., Rummel, M., Stiefel, O., Kerkhoff, A., Maulhardt, M., Melchardt, T., Pabst, T. N., Lenz, G., \u0026 Shumilov, E. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/177543\u0022\u003EOutcomes of pirtobrutinib for relapsed\/refractory mantle cell lymphoma in compassionate use program in Europe\u003C\/a\u003E. \u003Ci\u003ECancer Medicine\u003C\/i\u003E, \u003Ci\u003E13\u003C\/i\u003E(10).","year":2024,"type":"Journal Article (Original Article)"},{"title":"Shumilov, E., Mazzeo, P., Ghandili, S., K\u00fcnstner, A., Weidemann, S., Banz W\u00e4lti, Y. S., Str\u00f6bel, P., Pollak, M., Kolloch, L., Beltraminelli, H., Kerkhoff, A., Mikesch, J.-H., Schliemann, C., Haase, D., Wulf, G., Legros, M., Lenz, G., Feldmeyer, L., Pabst, T. N., \u2026 Bacher, V. U. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/173232\u0022\u003EDiagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations\u003C\/a\u003E. \u003Ci\u003EAnnals of Hematology\u003C\/i\u003E, \u003Ci\u003E103\u003C\/i\u003E(5), 1587-1599.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Muehlberg, L., Pabst, T. N., Largiad\u00e8r, C. R., Aebi, Y., Hayoz, M., M\u00fchlethaler, K., Zimmerli, S., \u0026 Hirzel, C. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/177686\u0022\u003EEvaluation of Posaconazole Serum Concentrations Achieved With Delayed-release Tablets and Oral Suspension in Patients Undergoing Intensive Chemotherapy for Acute Myeloid Leukemia and Myelodysplastic Syndrome\u003C\/a\u003E. \u003Ci\u003EOpen Forum Infectious Diseases\u003C\/i\u003E, \u003Ci\u003E11\u003C\/i\u003E(5).","year":2024,"type":"Journal Article (Original Article)"},{"title":"Hoffmann, M., Banz W\u00e4lti, Y. S., Halter, J., Schoumans, J., Tchinda, J., Bacher, V. U., \u0026 Pabst, T. N. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/177024\u0022\u003ETrue Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Considerations-Brief Report\u003C\/a\u003E. \u003Ci\u003ECurrent Oncology\u003C\/i\u003E, \u003Ci\u003E31\u003C\/i\u003E(4), 2067-2075.","year":2024,"type":"Journal Article (Further Contribution)"},{"title":"Seipel, K., Mandhair, H. K., Bacher, V. U., \u0026 Pabst, T. N. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/177026\u0022\u003EFLT3 and IRAK4 Inhibitor Emavusertib in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia\u003C\/a\u003E. \u003Ci\u003ECurrent Issues in Molecular Biology\u003C\/i\u003E, \u003Ci\u003E46\u003C\/i\u003E(4), 2946-2960.","year":2024,"type":"Journal Article (Original Article)"},{"title":"van der Maas, N. G., Versluis, J., Nasserinejad, K., van Rosmalen, J., Pabst, T. N., Maertens, J., Breems, D., Manz, M., Cloos, J., Ossenkoppele, G. J., Floisand, Y., Gradowska, P., L\u00f6wenberg, B., Huls, G., Postmus, D., Pignatti, F., \u0026 Cornelissen, J. J. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/176106\u0022\u003EBayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial\u003C\/a\u003E. \u003Ci\u003EBlood Cancer Journal\u003C\/i\u003E, \u003Ci\u003E14\u003C\/i\u003E(56).","year":2024,"type":"Journal Article (Original Article)"},{"title":"Berning, P., Shumilov, E., Maulhardt, M., Boyadzhiev, H., Kerkhoff, A., Call, S., Reicherts, C., Saidy, A. O., Aydilek, E., Hoffmann, M., Novak, U., Daskalakis, M., Schmitz, N., Stelljes, M., Wulf, G., Bacher, V. U., Lenz, G., \u0026 Pabst, T. N. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/175830\u0022\u003EChimeric antigen receptor-T cell therapy shows similar efficacy and toxicity in patients with diffuse large B-cell lymphoma aged 70 and older compared to younger patients: A multicenter cohort study\u003C\/a\u003E. \u003Ci\u003EHemaSphere\u003C\/i\u003E, \u003Ci\u003E8\u003C\/i\u003E(3), 1-12.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Heini, A. D., Bacher, V. U., Akhoundova, D., Seipel, K., \u0026 Pabst, T. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/194587\u0022\u003EPeeling Back the Layers: Recurrent Talquetamab Skin Toxicity After Supportive Stem Cell Boost in Multiple Myeloma\u003C\/a\u003E. \u003Ci\u003EActa Haematologica\u003C\/i\u003E, \u003Ci\u003E147\u003C\/i\u003E(6), 729-734.","year":2024,"type":"Journal Article (Further Contribution)"},{"title":"Bacher, V. U., Shumilov, E., \u0026 Pabst, T. N. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/171612\u0022\u003EIncreasing insight in the value of repetitive COVID-19 vaccination in patients with haematological malignancies in the Omicron era\u003C\/a\u003E. \u003Ci\u003EBritish Journal of Haematology\u003C\/i\u003E, \u003Ci\u003E204\u003C\/i\u003E(2), 386-388.","year":2024,"type":"Journal Article (Further Contribution)"},{"title":"Heini, A., Bacher, V. U., \u0026 Pabst, T. N. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/171398\u0022\u003EIdentification of novel targets for immunotherapies in subsets of patients with diffuse large B-cell lymphoma (DLBCL)\u003C\/a\u003E. \u003Ci\u003EBritish Journal of Haematology\u003C\/i\u003E, \u003Ci\u003E204\u003C\/i\u003E(2), 389-390.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Schmid, J. A., Festl, Y., Severin, Y., Bacher, V. U., Kronig, M.-N., Snijder, B., \u0026 Pabst, T. N. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/168683\u0022\u003EEfficacy and feasibility of pharmacoscopy-guided treatment for acute myeloid leukemia patients who have exhausted all registered therapeutic options\u003C\/a\u003E. \u003Ci\u003EHaematologica - the Hematology Journal\u003C\/i\u003E, \u003Ci\u003E109\u003C\/i\u003E(2), 617-621.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Beksac, M., Eikema, D.-J., Koster, L., Hulin, C., Poir\u00e9, X., Hamladji, R.-M., Gromek, T., Bazarbachi, A., Ozkurt, Z. N., Pabst, T., Ben Othman, T., Finke, J., Pirogova, O., Wu, D., Hayat, A., Hilgendorf, I., Tholouli, E., de Wreede, L. C., Sch\u00f6nland, S., \u2026 McLornan, D. P. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/194747\u0022\u003EIn the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E59\u003C\/i\u003E(4), 526-533.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Beyeler, M., Rea, E., Weber, L., Belachew, N. F., Barvulsky Aleman, E., Kielkopf, M. C., Kurmann, C. C., Grunder, L. N., Piechowiak, E. I., Meinel, T. R., Heldner, M. R., Seiffge, D. J., Pilgram-Pastor, S. M., Dobrocky, T., Pabst, T. N., Berger, M. D., Jung, S., Arnold, M., Gralla, J., \u2026 Mujanovi\u0107, A. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/171095\u0022\u003ESusceptibility vessel sign, a predictor of long-term outcome in patients with stroke treated with mechanical thrombectomy\u003C\/a\u003E. \u003Ci\u003EJournal of Neurointerventional Surgery\u003C\/i\u003E, \u003Ci\u003E16\u003C\/i\u003E(12), 1341-1347.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Volery, F., Banz, Y., Heini, A., Kronig, M.-N., Siegrist, D., Daskalakis, M., Bacher, U., \u0026 Pabst, T. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/188820\u0022\u003ETherapy-Related Acute Myeloid Leukemia after CAR-T Cell Therapy with Brexucabtagene Autoleucel for Mantle Cell Lymphoma\u003C\/a\u003E. \u003Ci\u003ECase Reports in Oncology\u003C\/i\u003E, \u003Ci\u003E17\u003C\/i\u003E(1), 1087-1093.","year":2024,"type":"Journal Article (Further Contribution)"},{"title":"Passweg, J. R., Baldomero, H., Ansari, M., Arber, C., Chalandon, Y., Daskalakis, M., Diepold, M., Diesch-Furlanetto, T., Duchosal, M. A., Gerull, S., G\u00fcng\u00f6r, T., Heim, D., Hitz, F., Holbro, A., Masouridi-Levrat, S., Nair, G., Novak, U., Pabst, T. N., Renner, C., \u2026 Halter, J. P. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172128\u0022\u003EHematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25\u00a0years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021\u003C\/a\u003E. \u003Ci\u003EHematological Oncology\u003C\/i\u003E, \u003Ci\u003E42\u003C\/i\u003E(1), e3241.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Fuchs, M., Jacob, A. S., Kaul, H., Kobe, C., Kuhnert, G., Pabst, T. N., Greil, R., Br\u00f6ckelmann, P. J., Topp, M. S., Just, M., Hertenstein, B., Soekler, M., Vogelhuber, M., Zijlstra, J. M., Keller, U. B., Krause, S. W., D\u00fchrsen, U., Meissner, J., Viardot, A., \u2026 Eichenauer, D. A. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/170712\u0022\u003EFollow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma\u003C\/a\u003E. \u003Ci\u003ELeukemia\u003C\/i\u003E, \u003Ci\u003E38\u003C\/i\u003E(1), 160-167.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Chen, J., Labopin, M., Pabst, T. N., Zhang, X., Jiang, E., Tucci, A., Cornelissen, J., Meijer, E., Khevelidze, I., Polge, E., Wu, D., Mohty, M., \u0026 Gorin, N.-C. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/169639\u0022\u003EAutologous stem cell transplantation in adult patients with intermediate-risk acute myeloid leukemia in first complete remission and no detectable minimal residual disease. A comparative retrospective study with haploidentical transplants of the global committee and the ALWP of the EBMT\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E58\u003C\/i\u003E(12), 1322-1330.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Perroud, C. H., Thurian, D. F., Andres, M., K\u00fcnzi, A. Y.-Y., Wiedemann, G., Zeerleder, S. S., Bacher, V. U., Pabst, T. N., Banz W\u00e4lti, Y. S., Porret, N., \u0026 Rebmann-Chigrinova, E. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/168765\u0022\u003EEffect of MAPK activation via mutations in NRAS, KRAS and BRAF on clinical outcome in newly diagnosed multiple myeloma\u003C\/a\u003E. \u003Ci\u003EHematological Oncology\u003C\/i\u003E, \u003Ci\u003E41\u003C\/i\u003E(5), 912-921.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Shumilov, E., Boyadzhiev, H., Mazzeo, P., Akhoundova Sanoyan, D., Daskalakis, M., Novak, U., Lenz, G., Bacher, V. U., \u0026 Pabst, T. N. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172008\u0022\u003ECAR-T Cell Therapy Shows Similar Efficacy and Toxicity in Patients With DLBCL Regardless of CNS Involvement\u003C\/a\u003E. \u003Ci\u003EHemaSphere\u003C\/i\u003E, \u003Ci\u003E7\u003C\/i\u003E(12), e984.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Tettero, J. M., Buisman, Y., Ngai, L. L., Bachas, C., Gjertsen, B. T., Kelder, A., van de Loosdrecht, A. A., Manz, M. G., Pabst, T. N., Scholten, W., Ossenkoppele, G. J., Cloos, J., \u0026 de Leeuw, D. C. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/171847\u0022\u003EPrognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML\u003C\/a\u003E. \u003Ci\u003EHemaSphere\u003C\/i\u003E, \u003Ci\u003E7\u003C\/i\u003E(12), e981.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Keil, F., M\u00fcller, A. M. S., Berghold, A., Riedl, R., Buxhofer-Ausch, V., Schuster, J., Vorburger, C. V., B\u00f6hm, A., Panny, M., N\u00f6sslinger, T., Greil, R., Samaras, P., Bencker, C., R\u00fctti, M., \u0026 Pabst, T. N. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/171851\u0022\u003EBendaEAM versus BEAM as conditioning regimen for ASCT in patients with relapsed lymphoma (BEB): a multicentre, randomised, phase 2 trial\u003C\/a\u003E. \u003Ci\u003EEClinicalMedicine\u003C\/i\u003E, \u003Ci\u003E66\u003C\/i\u003E(102318), 102318.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Pabst, T. N., Papayannidis, C., Demirkan, F., Doronin, V., Fogliatto, L. M., Guttke, C., Gyan, E., Hamad, N., Herrera, P., Hultberg, A., Jacobs, J., Johnson, A. J., Langlois, A., Ma, X., Martinelli, G., Arnan, M., M\u00fcller, R., Nottage, K., Ofran, Y., \u2026 Wei, A. H. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/171063\u0022\u003ECusatuzumab plus azacitidine in newly diagnosed acute myeloid leukaemia ineligible for intensive chemotherapy (CULMINATE): part one of a randomised, phase 2, dose optimisation study\u003C\/a\u003E. \u003Ci\u003EThe Lancet. Haematology\u003C\/i\u003E, \u003Ci\u003E10\u003C\/i\u003E(11), e902-e912.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Sanz, J., Labopin, M., Pabst, T. N., Versluis, J., Van Gorkom, G., Meijer, E., Gedde-Dahl, T., Montoro, J., Arcese, W., P\u00e9rez-Sim\u00f3n, J. A., Schaap, N., Maertens, J., Vrhovac, R., Lanza, F., Gorin, N. C., Mohty, M., \u0026 Ciceri, F. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/169161\u0022\u003EEtoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E58\u003C\/i\u003E(11), 1197-1202.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Tettero, J. M., Ngai, L. L., Bachas, C., Breems, D. A., Fischer, T., Gjertsen, B. T., Gradowska, P., Griskevicius, L., Janssen, J. J. W. M., Juliusson, G., Maertens, J., Manz, M. G., Pabst, T. N., Passweg, J., Porkka, K., Valk, P. J. M., L\u00f6wenberg, B., Ossenkoppele, G. J., \u0026 Cloos, J. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/166355\u0022\u003EMeasurable residual disease-guided therapy in intermediate-risk acute myeloid leukemia patients is a valuable strategy in reducing allogeneic transplantation without negatively affecting survival\u003C\/a\u003E. \u003Ci\u003EHaematologica - the Hematology Journal\u003C\/i\u003E, \u003Ci\u003E108\u003C\/i\u003E(10), 2794-2798.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Maru, B., Messikommer, A., Huang, L., Seipel, K., Kovecses, O., Valk, P. J. M., Theocharides, A. P. A., Mercier, F. E., Pabst, T. N., McKeague, M., \u0026 Luedtke, N. W. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/169886\u0022\u003EPARP-1 improves leukemia outcomes by inducing parthanatos during chemotherapy\u003C\/a\u003E. \u003Ci\u003ECell Reports. Medicine\u003C\/i\u003E, \u003Ci\u003E4\u003C\/i\u003E(9), 101191.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Sauer, S. T., Christner, S. A., Schlai\u00df, T., Metz, C., Schmid, A., Kunz, A. S., Pabst, T. N., Weiland, E., Benkert, T., Bley, T. A., \u0026 Grunz, J.-P. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/164865\u0022\u003EDiffusion-weighted Breast MRI at 3 Tesla: Improved Lesion Visibility and Image Quality with a Combination of Water-excitation and Spectral Fat Saturation\u003C\/a\u003E. \u003Ci\u003EAcademic Radiology\u003C\/i\u003E, \u003Ci\u003E30\u003C\/i\u003E(9), 1773-1783.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Bacher, V. U., Shumilov, E., \u0026 Pabst, T. N. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/169030\u0022\u003EBenefit of repeated COVID-19 vaccination for patients with B-cell malignancies\u003C\/a\u003E. \u003Ci\u003EBritish Journal of Haematology\u003C\/i\u003E, \u003Ci\u003E202\u003C\/i\u003E(6), 1081-1083.","year":2023,"type":"Journal Article (Further Contribution)"},{"title":"Messerli, C., Wiedemann, G., Porret, N., Nagler, M., Seipel, K., Jeker, B., Novak, U., Zeerleder, S. S., Bacher, V. U., \u0026 Pabst, T. N. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/169029\u0022\u003ECorrelation of peripheral chimeric antigen receptor T-cell (CAR-T cell) mRNA expression levels with toxicities and outcome in patients with diffuse large B-cell lymphoma (DLBCL)\u003C\/a\u003E. \u003Ci\u003ETurkish Journal of Haematology\u003C\/i\u003E, \u003Ci\u003E40\u003C\/i\u003E(3), 187-196.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Seipel, K., Kohler, S., Bacher, V. U., \u0026 Pabst, T. N. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/170295\u0022\u003EHSP90 Inhibitor PU-H71 in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia\u003C\/a\u003E. \u003Ci\u003ECurrent Issues in Molecular Biology\u003C\/i\u003E, \u003Ci\u003E45\u003C\/i\u003E(9), 7011-7026.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Maechler, M., Bacher, V. U., Daskalakis, M., Nilius, H. J. J., Nagler, M., Mansouri Taleghani, B., Jeker, B., \u0026 Pabst, T. N. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/86505\u0022\u003ELong-term safety of the stem cell releasing compound plerixafor for peripheral stem cell collection in myeloma patients\u003C\/a\u003E. \u003Ci\u003EHematological Oncology\u003C\/i\u003E, \u003Ci\u003E41\u003C\/i\u003E(3), 583-586.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Haefliger, D., Marzolini, C., Lamoth, F., Pabst, T. N., Buclin, T., \u0026 Livio, F. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/166444\u0022\u003EClinically relevant bidirectional drug-drug interaction between midostaurin and voriconazole\u003C\/a\u003E. \u003Ci\u003EBritish Journal of Clinical Pharmacology\u003C\/i\u003E, \u003Ci\u003E89\u003C\/i\u003E(7), 2304-2308.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Pabst, T. N., Vey, N., Ad\u00e8s, L., Bacher, V. U., Bargetzi, M., Fung, S., Gaidano, G., Gandini, D., Hultberg, A., Johnson, A., Ma, X., M\u00fcller, R., Nottage, K., Papayannidis, C., Recher, C., Riether, C., Shah, P., Tryon, J., Xiu, L., \u0026 Ochsenbein, A. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/121569\u0022\u003EResults from a phase I\/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy\u003C\/a\u003E. \u003Ci\u003EHaematologica - the Hematology Journal\u003C\/i\u003E, \u003Ci\u003E108\u003C\/i\u003E(7), 1793-1802.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Hilberink, J. R., van Zeventer, I. A., Chitu, D. A., Pabst, T. N., Klein, S. K., Stussi, G., Griskevicius, L., Valk, P. J. M., Cloos, J., van de Loosdrecht, A. A., Breems, D., van Lammeren-Venema, D., Boersma, R., Jongen-Lavrencic, M., Fehr, M., Hoogendoorn, M., Manz, M. G., S\u00f6hne, M., van Marwijk Kooy, R., \u2026 Huls, G. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/167950\u0022\u003EAge and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine\u003C\/a\u003E. \u003Ci\u003EBlood Cancer Journal\u003C\/i\u003E, \u003Ci\u003E13\u003C\/i\u003E(1), 93.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Seipel, K., Abb\u00fchl, M., Bacher, V. U., Nilius, H. J. J., Daskalakis, M., \u0026 Pabst, T. N. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/167749\u0022\u003EClinical Impact of Single Nucleotide Polymorphism in CD-19 on Treatment Outcome in FMC63-CAR-T Cell Therapy\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E15\u003C\/i\u003E(11).","year":2023,"type":"Journal Article (Original Article)"},{"title":"Ngai, L. L., Hanekamp, D., Janssen, F., Carbaat-Ham, J., Hofland, M. A. M., Fayed, M. M. H. E., Kelder, A., Oudshoorn-van Marsbergen, L., Scholten, W. J., Snel, A. N., Bachas, C., Tettero, J. M., Breems, D. A., Fischer, T., Gjertsen, B. T., Griskevicius, L., Juliusson, G., van de Loosdrecht, A. A., Maertens, J. A., \u2026 Cloos, J. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/166519\u0022\u003EProspective Validation of the Prognostic Relevance of CD34+CD38- AML Stem Cell frequency in the HOVON-SAKK132 trial\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E141\u003C\/i\u003E(21), 2657-2661.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Gillich, C., Akhoundova Sanoyan, D., Hayoz, M., Aebi, Y., Largiad\u00e8r, C. R., Seipel, K., Daskalakis, M., Bacher, V. U., \u0026 Pabst, T. N. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/168090\u0022\u003EEfficacy and Safety of High-Dose Chemotherapy with Treosulfan and Melphalan in Multiple Myeloma\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E15\u003C\/i\u003E(10).","year":2023,"type":"Journal Article (Original Article)"},{"title":"von Matt, S., Bacher, V. U., Banz W\u00e4lti, Y. S., Mansouri Taleghani, B., Novak, U., \u0026 Pabst, T. N. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/167114\u0022\u003EOutcome of Patients with Diffuse Large B-Cell Lymphoma Relapsing after Autologous Transplant before Availability of CAR-T Cell Treatment\u003C\/a\u003E. \u003Ci\u003EMediterranean Journal of Hematology and Infectious Diseases\u003C\/i\u003E, \u003Ci\u003E15\u003C\/i\u003E(1), e2023025.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Akhoundova Sanoyan, D., Seipel, K., Bacher, V. U., Kronig, M.-N., Porret, N., Wiedemann, G., Daskalakis, M., \u0026 Pabst, T. N. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/166490\u0022\u003EReal-life experiences with CAR T-cell therapy with idecabtagene vicleucel (ide-cel)\u00a0for triple-class exposed relapsed\/refractory multiple myeloma patients\u003C\/a\u003E. \u003Ci\u003EBMC Cancer\u003C\/i\u003E, \u003Ci\u003E23\u003C\/i\u003E(1), 345.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Huwyler, F. A. F., Kunz, R., Bacher, V. U., Hoffmann, M., Novak, U., Daskalakis, M., Banz W\u00e4lti, Y. S., \u0026 Pabst, T. N. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/166447\u0022\u003EEvaluation of Bortezomib-BeEAM (2BeEAM) as Chemotherapy Regimen Prior to ASCT in Patients with Mantle Cell Lymphoma\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E15\u003C\/i\u003E(7).","year":2023,"type":"Journal Article (Original Article)"},{"title":"Heini, A., Beck, P., Bacher, V. U., Seipel, K., Zander, T., Daskalakis, M., \u0026 Pabst, T. N. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/165943\u0022\u003EBeEAM Conditioning including High-Dose Bendamustine before Autologous Stem Cell Transplantation Is Safe and Effective in Patients with Waldenstrom\u2019s Macroglobulinemia\u003C\/a\u003E. \u003Ci\u003EJournal of Clinical Medicine\u003C\/i\u003E, \u003Ci\u003E12\u003C\/i\u003E(6).","year":2023,"type":"Journal Article (Original Article)"},{"title":"Wittibschlager, V., Bacher, V. U., Seipel, K., Porret, N., Wiedemann, G., Haslebacher, C., Hoffmann, M., Daskalakis, M., Akhoundova Sanoyan, D., \u0026 Pabst, T. N. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/165944\u0022\u003ECAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma\u003C\/a\u003E. \u003Ci\u003EInternational Journal of Molecular Sciences\u003C\/i\u003E, \u003Ci\u003E24\u003C\/i\u003E(6).","year":2023,"type":"Journal Article (Original Article)"},{"title":"Zander, T., Pabst, T. N., Sch\u00e4r, S., Aebi, S., Mey, U., Novak, U., Lerch, E., Rhyner Agocs, G., Goede, J., Maniecka, Z., Hayoz, S., R\u00fcfer, A., Renner, C., \u0026 Driessen, C. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/120489\u0022\u003EAlternate-day dosing of pomalidomide in relapsed\/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial\u003C\/a\u003E. \u003Ci\u003ELeukemia\u003C\/i\u003E, \u003Ci\u003E37\u003C\/i\u003E(3), 699-701.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Lakomy, T., Akhoundova Sanoyan, D., Nilius, H. J. J., Kronig, M.-N., Novak, U., Daskalakis, M., Bacher, V. U., \u0026 Pabst, T. N. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/164510\u0022\u003EEarly Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome\u003C\/a\u003E. \u003Ci\u003EBiomolecules\u003C\/i\u003E, \u003Ci\u003E13\u003C\/i\u003E(2).","year":2023,"type":"Journal Article (Original Article)"},{"title":"B\u00fchler, S., Akhoundova Sanoyan, D., Jeker, B., Legros, M., Seipel, K., Daskalakis, M., Bacher, V. U., \u0026 Pabst, T. N. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/120820\u0022\u003EStem Cell Mobilization with Ixazomib and G-CSF in Patients with Multiple Myeloma\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E15\u003C\/i\u003E(2).","year":2023,"type":"Journal Article (Original Article)"},{"title":"Beyeler, M., Grunder, L. N., G\u00f6cmen, J., Steinauer, F., Belachew, N. F., Kielkopf, M. C., Cl\u00e9nin, L. C., M\u00fcller, M., Silimon, N., Kurmann, C. C., Meinel, T. R., B\u00fccke, P. J., Seiffge, D. J., Dobrocky, T., Piechowiak, E. I., Pilgram-Pastor, S. M., Mattle, H., Navi, B. B., Arnold, M., \u2026 Kaesmacher, J. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/166356\u0022\u003EAbsence of susceptibility vessel sign and hyperdense vessel sign in patients with cancer-related stroke\u003C\/a\u003E. \u003Ci\u003EFrontiers in Neurology\u003C\/i\u003E, \u003Ci\u003E14\u003C\/i\u003E(1148152), 1148152.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Qiu, P., \u0026 Pabst, T. N. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172465\u0022\u003ECharacterization of particle size segregation and heterogeneity along the slopes of a waste rock pile using image analysis\u003C\/a\u003E. \u003Ci\u003EEnvironmental Earth Science\u003C\/i\u003E, \u003Ci\u003E82\u003C\/i\u003E(23), 573.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Seipel, K., Frey, M., Nilius, H. J. J., Akhoundova Sanoyan, D., Banz W\u00e4lti, Y. S., Bacher, V. U., \u0026 Pabst, T. N. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172451\u0022\u003ELow-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma\u003C\/a\u003E. \u003Ci\u003ECurrent Oncology\u003C\/i\u003E, \u003Ci\u003E30\u003C\/i\u003E(12), 10463-10476.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Bohler, J., Bacher, V. U., Banz W\u00e4lti, Y. S., Stadelmann, R., Medinger, M., Zander, T., \u0026 Pabst, T. N. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/116864\u0022\u003EBlinatumomab in Relapsed\/Refractory Burkitt Lymphoma\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E15\u003C\/i\u003E(1), 44.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Beyeler, M., Castigliego, P., Baumann, J., Ziegler, V., Kielkopf, M. C., M\u00fcller, M., Bauer, S., Mujanovic, A., Meinel, T. R., Horvath, T. N., Fischer, U. M., Kaesmacher, J., Heldner, M. R., Seiffge, D. J., Arnold, M., Pabst, T. N., Berger, M. D., Navi, B. B., Jung, S., \u0026 B\u00fccke, P. J. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/170701\u0022\u003ETransient ischemic attacks in patients with active and occult cancer\u003C\/a\u003E. \u003Ci\u003EFrontiers in Neurology\u003C\/i\u003E, \u003Ci\u003E14\u003C\/i\u003E(1268131), 1268131.","year":2023,"type":"Journal Article (Original Article)"},{"title":"R\u00fcegsegger, L., Schanz, U., Seipel, K., Pabst, T. N., Schwegler, J., Schmidt, E., \u0026 Schmidt, A. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/166417\u0022\u003EEmberger Syndrome \u2013 A Family History Over 3 Generations\u003C\/a\u003E. \u003Ci\u003EHealthbook TIMES Oncology Hematology\u003C\/i\u003E, \u003Ci\u003E14\u003C\/i\u003E(4), 34-40.","year":2022,"type":"Journal Article (Further Contribution)"},{"title":"Seipel, K., Br\u00fcgger, Y. A., Mandhair, H., Bacher, V. U., \u0026 Pabst, T. N. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/88425\u0022\u003ERationale for Combining the BCL2 Inhibitor Venetoclax with the PI3K Inhibitor Bimiralisib in the Treatment of IDH2- and FLT3-Mutated Acute Myeloid Leukemia\u003C\/a\u003E. \u003Ci\u003EInternational Journal of Molecular Sciences\u003C\/i\u003E, \u003Ci\u003E23\u003C\/i\u003E(20).","year":2022,"type":"Journal Article (Original Article)"},{"title":"Rebmann-Chigrinova, E., Porret, N., Andres, M., Wiedemann, G., Banz W\u00e4lti, Y. S., Legros, M., Pollak, M., Oppliger Leibundgut, E., Pabst, T. N., \u0026 Bacher, V. U. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/87711\u0022\u003ECorrelation of plasma cell assessment by phenotypic methods and molecular profiles by NGS in patients with plasma cell dyscrasias\u003C\/a\u003E. \u003Ci\u003EBMC Medical Genomics\u003C\/i\u003E, \u003Ci\u003E15\u003C\/i\u003E(1), 203.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Rausch, C., Bacher, V. U., Rabaglio, M. E., Vorburger, C. V., Klingenberg-Rettich, A., Banz W\u00e4lti, Y. S., Daskalakis, M., \u0026 Pabst, T. N. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/87699\u0022\u003ECombining BeEAM with Brentuximab Vedotin for High-Dose Therapy in CD30 Positive Lymphomas before Autologous Transplantation-A Phase I Study\u003C\/a\u003E. \u003Ci\u003EJournal of Clinical Medicine\u003C\/i\u003E, \u003Ci\u003E11\u003C\/i\u003E(18).","year":2022,"type":"Journal Article (Original Article)"},{"title":"Heini, A., Bacher, V. U., Porret, N., Wiedemann, G., Legros, M., Stalder Zeerleder, D., Seipel, K., Novak, U., Daskalakis, M., \u0026 Pabst, T. N. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/87350\u0022\u003EExperiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma\u003C\/a\u003E. \u003Ci\u003ECells\u003C\/i\u003E, \u003Ci\u003E11\u003C\/i\u003E(17).","year":2022,"type":"Journal Article (Original Article)"},{"title":"Janssen, J. J. W. M., L\u00f6wenberg, B., Manz, M., Biemond, B. J., Westerweel, P. E., Klein, S. K., Fehr, M., Sinnige, H. A. M., Efthymiou, A., Legdeur, M. C. J. C., Pabst, T. N., Gregor, M., van der Poel, M. W. M., Deeren, D., Tick, L. W., Jongen-Lavrencic, M., van Obbergh, F., Boersma, R. S., de Weerdt, O., \u2026 Ossenkoppele, G. J. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/86348\u0022\u003EAddition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome\u003C\/a\u003E. \u003Ci\u003ELeukemia\u003C\/i\u003E, \u003Ci\u003E36\u003C\/i\u003E(9), 2189-2195.","year":2022,"type":"Journal Article (Original Article)"},{"title":"G\u00f6ssi, S., Bacher, V. U., Haslebacher, C., Nagler, M., Suter, F. M., Staehelin, C., Novak, U., \u0026 Pabst, T. N. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/86406\u0022\u003EHumoral Responses to Repetitive Doses of COVID-19 mRNA Vaccines in Patients with CAR-T-Cell Therapy\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E14\u003C\/i\u003E(14).","year":2022,"type":"Journal Article (Original Article)"},{"title":"Beyeler, M., Belachew, N. F., Kielkopf, M. C., Aleman, E. B., L\u00e9on Betancourt, A. X., Genceviciute, K., Kurmann, C. C., Grunder, L. N., Birner, B., Meinel, T. R., Scutelnic, A., B\u00fccke, P. J., Seiffge, D. J., Dobrocky, T., Piechowiak, E. I., Pilgram-Pastor, S. M., Mattle, H., Mordasini, P. R., Arnold, M., \u2026 Kaesmacher, J. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/86460\u0022\u003EAbsence of Susceptibility Vessel Sign in Patients With Malignancy-Related Acute Ischemic Stroke Treated With Mechanical Thrombectomy\u003C\/a\u003E. \u003Ci\u003EFrontiers in Neurology\u003C\/i\u003E, \u003Ci\u003E13\u003C\/i\u003E, 930635.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Stoffel, T., Bacher, V. U., Banz W\u00e4lti, Y. S., Daskalakis, M., Novak, U., \u0026 Pabst, T. N. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/86080\u0022\u003EBeEAM High-Dose Chemotherapy with Polatuzumab (Pola-BeEAM) before ASCT in Patients with DLBCL-A Pilot Study\u003C\/a\u003E. \u003Ci\u003EJournal of Clinical Medicine\u003C\/i\u003E, \u003Ci\u003E11\u003C\/i\u003E(13).","year":2022,"type":"Journal Article (Original Article)"},{"title":"Beyeler, M., Birner, B., Branca, M., Meinel, T. R., Vynckier, J. L., Buffle, E. J., Scutelnic, A., Heldner, M. R., B\u00fccke, P. J., Seiffge, D. J., Mordasini, P. R., Dobrocky, T., Piechowiak, E. I., Kaesmacher, J., Gralla, J., Mattle, H., Arnold, M., Fischer, U. M., Pabst, T. N., \u2026 Jung, S. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/85890\u0022\u003EDevelopment of a score for prediction of occult malignancy in stroke patients (occult-5 score)\u003C\/a\u003E. \u003Ci\u003EJournal of Stroke and Cerebrovascular Diseases\u003C\/i\u003E, \u003Ci\u003E31\u003C\/i\u003E(8), 106609.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Heini, A., Bacher, V. U., Kronig, M.-N., Wiedemann, G., Novak, U., Zeerleder, S. S., Mansouri Taleghani, B., Daskalakis, M., \u0026 Pabst, T. N. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/70016\u0022\u003EChimeric antigen receptor T-cell therapy for relapsed mantle cell lymphoma: real-world experience from a single tertiary care center\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E57\u003C\/i\u003E(6), 1010-1012.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Farag, S. A. I., Bacher, V. U., Jeker, B., Legros, M., Rhyner, G., L\u00fcthi, J.-M., Schardt, J., Zander, T., Daskalakis, M., Mansouri Taleghani, B., Manz, C., \u0026 Pabst, T. N. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/70302\u0022\u003EAdding bendamustine to melphalan before ASCT improves CR rate in myeloma vs. melphalan alone: A randomized phase-2 trial\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E57\u003C\/i\u003E(6), 990-997.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Rentsch, V., Seipel, K., Banz W\u00e4lti, Y. S., Wiedemann, G., Porret, N., Bacher, V. U., \u0026 Pabst, T. N. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/85330\u0022\u003EGlofitamab Treatment in Relapsed or Refractory DLBCL after CAR T-Cell Therapy\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E14\u003C\/i\u003E(10).","year":2022,"type":"Journal Article (Original Article)"},{"title":"Linnik, J., Syedbasha, M., Kaltenbach, H.-M., Vogt, D., Hollenstein, Y., Kaufmann, L., Cantoni, N., Ruosch-Girsberger, S., M\u00fcller, A. M. S., Schanz, U., Pabst, T. N., St\u00fcssi, G., Weisser, M., Halter, J., Stelling, J., \u0026 Egli, A. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/88616\u0022\u003EAssociation of Host Factors With Antibody Response to Seasonal Influenza Vaccination in Allogeneic Hematopoietic Stem Cell Transplant Patients\u003C\/a\u003E. \u003Ci\u003EThe Journal of Infectious Diseases\u003C\/i\u003E, \u003Ci\u003E225\u003C\/i\u003E(8), 1482-1493.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Grob, T., Al Hinai, A. S. A., Sanders, M. A., Kavelaars, F. G., Rijken, M., Gradowska, P. L., Biemond, B. J., Breems, D. A., Maertens, J., van Marwijk Kooy, M., Pabst, T. N., de Weerdt, O., Ossenkoppele, G. J., van de Loosdrecht, A. A., Huls, G. A., Cornelissen, J. J., Beverloo, H. B., L\u00f6wenberg, B., Jongen-Lavrencic, M., \u0026 Valk, P. J. M. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/87510\u0022\u003EMolecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E139\u003C\/i\u003E(15), 2347-2354.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Kreissl, S., Voltin, C., Kaul, H., B\u00fchnen, I., Mettler, J., Pabst, T. N., Eichenauer, D. A., Fuchs, M., Diehl, V., Dietlein, M., Engert, A., Borchmann, P., \u0026 Kobe, C. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/59364\u0022\u003EImpact of bone marrow involvement on early positron emission tomography response and progression\u2010free survival in the HD18 trial for patients with advanced\u2010stage Hodgkin lymphoma\u003C\/a\u003E. \u003Ci\u003EBritish Journal of Haematology\u003C\/i\u003E, \u003Ci\u003E197\u003C\/i\u003E(1), e5-e8.","year":2022,"type":"Journal Article (Further Contribution)"},{"title":"Mathys, A., Bacher, V. U., Banz W\u00e4lti, Y. S., Legros, M., Mansouri Taleghani, B., Novak, U., \u0026 Pabst, T. N. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/57810\u0022\u003EOutcome of patients with mantle cell lymphoma after autologous stem cell transplantation in the pre-CAR T-cell era Letter\u003C\/a\u003E. \u003Ci\u003EHematological Oncology\u003C\/i\u003E, \u003Ci\u003E40\u003C\/i\u003E(2), 292-296.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Seipel, K., Porret, N., Wiedemann, G., Jeker, B., Bacher, V. U., \u0026 Pabst, T. N. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/85744\u0022\u003EsBCMA Plasma Level Dynamics and Anti-BCMA CAR-T-Cell Treatment in Relapsed Multiple Myeloma\u003C\/a\u003E. \u003Ci\u003ECurrent Issues in Molecular Biology\u003C\/i\u003E, \u003Ci\u003E44\u003C\/i\u003E(4), 1463-1471.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Gurevich, E., Hayoz, M., Aebi, Y., Largiad\u00e8r, C. R., Mansouri Taleghani, B., Bacher, V. U., \u0026 Pabst, T. N. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/67881\u0022\u003EComparison of Melphalan Combined with Treosulfan or Busulfan as High-Dose Chemotherapy before Autologous Stem Cell Transplantation in AML\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E14\u003C\/i\u003E(4).","year":2022,"type":"Journal Article (Original Article)"},{"title":"Shumilov, E., Shakhanova, I., Flach, J., Schmidt, N., B\u00fcrki, S., Legros, M., Kronig, M.-N., Ofran, Y., Gerull, S., Medinger, M., Mansouri Taleghani, B., Passweg, J., Halter, J., Bacher, V. U., \u0026 Pabst, T. N. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/57807\u0022\u003EFeasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E57\u003C\/i\u003E(2), 224-231.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Bakunina, K., Putter, H., Versluis, J., Koster, E. A. S., van der Holt, B., Manz, M. G., Breems, D. A., Gjertsen, B. T., Cloos, J., Valk, P. J. M., Passweg, J., Pabst, T. N., Ossenkoppele, G. J., L\u00f6wenberg, B., Cornelissen, J. J., \u0026 de Wreede, L. C. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/59361\u0022\u003EThe added value of multi-state modelling in a randomized controlled trial: The HOVON 102 study re-analyzed\u003C\/a\u003E. \u003Ci\u003ECancer Medicine\u003C\/i\u003E, \u003Ci\u003E11\u003C\/i\u003E(3), 630-640.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Shumilov, E., Mazzeo, P., Zinkernagel, M. S., Legros, M., Porret, N., Romagna, L., Haase, D., Lenz, G., Novak, U., Banz W\u00e4lti, Y. S., Pabst, T. N., \u0026 Bacher, V. U. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/67830\u0022\u003EComprehensive Laboratory Diagnostic Workup for Patients with Suspected Intraocular Lymphoma including Flow Cytometry, Molecular Genetics and Cytopathology\u003C\/a\u003E. \u003Ci\u003ECurrent Oncology\u003C\/i\u003E, \u003Ci\u003E29\u003C\/i\u003E(2), 766-776.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Tettero, J. M., Al-Badri, W. K. W., Ngai, L. L., Bachas, C., Breems, D. A., van Elssen, C. H. M. J., Fischer, T., Gjertsen, B. T., van Gorkom, G. N. Y., Gradowska, P., Greuter, M. J. E., Griskevicius, L., Juliusson, G., Maertens, J., Manz, M. G., Pabst, T. N., Passweg, J., Porkka, K., L\u00f6wenberg, B., \u2026 Cloos, J. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/88417\u0022\u003EConcordance in measurable residual disease result after first and second induction cycle in acute myeloid leukemia: An outcome- and cost-analysis\u003C\/a\u003E. \u003Ci\u003EFrontiers in Oncology\u003C\/i\u003E, \u003Ci\u003E12\u003C\/i\u003E, 999822.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Heidemeier, A., Thurner, A., Metz, C., Pabst, T. N., Heidemeier, H., Rasche, L., Kort\u00fcm, K. M., Einsele, H., Grimm, R., Weiland, E., \u0026 Bley, T. A. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/38589\u0022\u003EWhole-Body MRI with an Ultrahigh b-Value of 2000 s\/mm2 Improves the Specificity of Diffusion-Weighted Imaging in Patients with Plasma Cell Dyscrasias\u003C\/a\u003E. \u003Ci\u003EAcademic Radiology\u003C\/i\u003E, \u003Ci\u003E29\u003C\/i\u003E(1), e1-e8.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Messmer, A. S., Que, Y.-A., Schankin, C. J., Banz W\u00e4lti, Y. S., Bacher, V. U., Novak, U., \u0026 Pabst, T. N. (2021). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/53710\u0022\u003ECAR T-cell therapy and critical care : A\u00a0survival guide for medical emergency teams.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EWiener Klinische Wochenschrift\u003C\/i\u003E, \u003Ci\u003E133\u003C\/i\u003E(23-24), 1318-1325.","year":2021,"type":"Journal Article (Review)"},{"title":"Condoluci, A., Th\u00e9audin, M., Schwotzer, R., Pazhenkottil, A. P., Arosio, P., Averaimo, M., Bacher, V. U., Bode, P., Cavalli, A., Dirnhofer, S., Djerbi, N., Dobner, S., Fehr, T., Garofalo, M., Gaspert, A., Gerull, S., Heimgartner, R., H\u00fcbers, A., Jung, H. H., \u2026 Gerber, B. (2021). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/54246\u0022\u003EManagement of transthyretin amyloidosis.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003ESwiss Medical Weekly\u003C\/i\u003E, \u003Ci\u003E151\u003C\/i\u003E(w30053), w30053.","year":2021,"type":"Journal Article (Review)"},{"title":"Messmer, A. S., Que, Y.-A., Schankin, C. J., Banz W\u00e4lti, Y. S., Bacher, V. U., Novak, U., \u0026 Pabst, T. N. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/54247\u0022\u003ENovel Adaptive T-Cell Oncological Treatments Lead to New Challenges for Medical Emergency Teams: A 2-Year Experience From a Tertiary-Care Hospital in Switzerland\u003C\/a\u003E. \u003Ci\u003ECritical Care Explorations\u003C\/i\u003E, \u003Ci\u003E3\u003C\/i\u003E(10), e0552.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Peter, R., Halter, J. P., Heim, D., Medinger, M., Pabst, T. N., Stussi, G., Passweg, J. R., \u0026 Gerull, S. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/43666\u0022\u003ELack of association of travel time to transplant center and posttransplant care model with outcome parameters after allogeneic transplantation\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E56\u003C\/i\u003E(8), 2024-2026.","year":2021,"type":"Journal Article (Further Contribution)"},{"title":"Stamm, S. L., Spichiger, E., Pabst, T. N., Bachnick, S., \u0026 Jeitziner, M.-M. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/57050\u0022\u003ESymptom prevalence and health-related quality of life in patients undergoing autologous stem cell transplantation - A longitudinal observational study\u003C\/a\u003E. \u003Ci\u003EEuropean Journal of Oncology Nursing\u003C\/i\u003E, \u003Ci\u003E53\u003C\/i\u003E, 101997.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Damonti, L., Buetti, N. I. M.-A., Droz, S. C., Bacher, V. U., Pabst, T. N., Mansouri Taleghani, B., B\u00e4rlocher, G. M., \u0026 Marschall, J. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/41969\u0022\u003EPrevalence and significance of bacterial contamination of autologous stem cell products\u003C\/a\u003E. \u003Ci\u003EThe Journal of Hospital Infection\u003C\/i\u003E, \u003Ci\u003E114\u003C\/i\u003E, 175-179.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Seipel, K., Graber, C., Fl\u00fcckiger, L., Bacher, V. U., \u0026 Pabst, T. N. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/43693\u0022\u003ERationale for a Combination Therapy with the STAT5 Inhibitor AC-4-130 and the MCL1 Inhibitor S63845 in the Treatment of FLT3-Mutated or TET2-Mutated Acute Myeloid Leukemia\u003C\/a\u003E. \u003Ci\u003EInternational Journal of Molecular Sciences\u003C\/i\u003E, \u003Ci\u003E22\u003C\/i\u003E(15).","year":2021,"type":"Journal Article (Original Article)"},{"title":"Heini, A., Porret, N., Zenhaeusern, R., Winkler, A., Bacher, V. U., \u0026 Pabst, T. N. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/42629\u0022\u003EClonal Hematopoiesis after Autologous Stem Cell Transplantation Does Not Confer Adverse Prognosis in Patients with AML\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E13\u003C\/i\u003E(13).","year":2021,"type":"Journal Article (Original Article)"},{"title":"Kreissl, S., Goergen, H., Buehnen, I., Kobe, C., Moccia, A., Greil, R., Eichenauer, D. A., Zijlstra, J. M., Markova, J., Meissner, J., Feuring-Buske, M., Soekler, M., Beck, H.-J., Willenbacher, W., Ludwig, W.-D., Pabst, T. N., Topp, M. S., Hitz, F., Bentz, M., \u2026 Borchmann, P. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/43669\u0022\u003EPET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial\u003C\/a\u003E. \u003Ci\u003EThe Lancet. Haematology\u003C\/i\u003E, \u003Ci\u003E8\u003C\/i\u003E(6), e398-e409.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Messikomer, A., Bruktawit, M., Seipel, K., Valk, P., Theocharides, A., Pabst, T. N., Mckeague, M., \u0026 Luedtke, N. (2021). \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/66534\u0022\u003ECancer Prognosis According to Parthanatos Features\u003C\/a\u003E\u003C\/i\u003E. Cold Spring Harbor Laboratory.","year":2021,"type":"Working Paper"},{"title":"Brune, M. M., St\u00fcssi, G., Lundberg, P., Vela, V., Heim, D., Manz, M. G., Haralambieva, E., Pabst, T. N., Banz W\u00e4lti, Y. S., Bargetzi, M., Grobholz, R., Fehr, M., Cogliatti, S., Ossenkoppele, G. J., L\u00f6wenberg, B., Rudolf, C. B., Li, Q., Passweg, J., Mazzuchelli, L., \u2026 Tzankov, A. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/43665\u0022\u003EEffects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML\/SAKK30\/10 Swiss trial cohort\u003C\/a\u003E. \u003Ci\u003EAnnals of Hematology\u003C\/i\u003E, \u003Ci\u003E100\u003C\/i\u003E(5), 1169-1179.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Moret, F., Marschall, J., Atkinson, A., Farag, S. A. I., Zimmerli, S., Pabst, T. N., \u0026 Sommerstein, R. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/56115\u0022\u003ECharacteristics of respiratory virus infections in autologous hematopoietic stem cell transplantation patients, a prospective study, Bern, Switzerland, 2015-2017\u003C\/a\u003E. \u003Ci\u003EInfectious Diseases\u003C\/i\u003E, \u003Ci\u003E53\u003C\/i\u003E(4), 274-280.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Pabst, T. N., \u0026 Bacher, V. U. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/40314\u0022\u003ERisk stratification systems for allogeneic haematopoietic stem-cell transplantation\u003C\/a\u003E. \u003Ci\u003EThe Lancet. Haematology\u003C\/i\u003E, \u003Ci\u003E8\u003C\/i\u003E(3), e166-e167.","year":2021,"type":"Journal Article (Further Contribution)"},{"title":"L\u00f6wenberg, B., Pabst, T. N., Maertens, J., Gradowska, P., Biemond, B. J., Spertini, O., Vellenga, E., Griskevicius, L., Tick, L. W., Jongen-Lavrencic, M., van Marwijk Kooy, M., Vekemans, M.-C., van der Velden, W. J. F. M., Beverloo, B., Michaux, L., Graux, C., Deeren, D., de Weerdt, O., van Esser, J. W. J., \u2026 Ossenkoppele, G. J. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/43660\u0022\u003EAddition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial\u003C\/a\u003E. \u003Ci\u003EBlood Advances\u003C\/i\u003E, \u003Ci\u003E5\u003C\/i\u003E(4), 1110-1121.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Janssen, J., L\u00f6wenberg, B., Manz, M., Bargetzi, M., Biemond, B., Borne, P. von dem, Breems, D., Brouwer, R., Chalandon, Y., Deeren, D., Efthymiou, A., Gjertsen, B.-T., Graux, C., Gregor, M., Heim, D., Hess, U., Hoogendoorn, M., Jaspers, A., Jie, A., \u2026 Ossenkoppele, G. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/43661\u0022\u003EInferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E13\u003C\/i\u003E(4).","year":2021,"type":"Journal Article (Original Article)"},{"title":"Seipel, K., Kopp, B., Bacher, V. U., \u0026 Pabst, T. N. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/45418\u0022\u003EBMI1-Inhibitor PTC596 in Combination with MCL1 Inhibitor S63845 or MEK Inhibitor Trametinib in the Treatment of Acute Leukemia\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E13\u003C\/i\u003E(3).","year":2021,"type":"Journal Article (Original Article)"},{"title":"Betticher, C., Bacher, V. U., Legros, M., Zimmerli, S., Banz W\u00e4lti, Y. S., Mansouri Taleghani, B., \u0026 Pabst, T. N. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/37433\u0022\u003EProphylactic corticosteroid use prevents engraftment syndrome in patients after autologous stem cell transplantation\u003C\/a\u003E. \u003Ci\u003EHematological Oncology\u003C\/i\u003E, \u003Ci\u003E39\u003C\/i\u003E(1), 97-104.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Borchmann, P., Pl\u00fctschow, A., Kobe, C., Greil, R., Meissner, J., Topp, M. S., Ostermann, H., Dierlamm, J., Mohm, J., Thiemer, J., S\u00f6kler, M., Kerkhoff, A., Ahlborn, M., Halbsguth, T. V., Martin, S., Keller, U., Balabanov, S., Pabst, T. N., Vogelhuber, M., \u2026 Engert, A. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/43662\u0022\u003EPET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial\u003C\/a\u003E. \u003Ci\u003EThe Lancet Oncology\u003C\/i\u003E, \u003Ci\u003E22\u003C\/i\u003E(2), 223-234.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Br\u00f6ckelmann, P. J., M\u00fcller, H., Guhl, T., Behringer, K., Fuchs, M., Moccia, A. A., Rank, A., Soekler, M., Vieler, T., Pabst, T. N., Baues, C., von Tresckow, B., Borchmann, P., \u0026 Engert, A. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/37770\u0022\u003ERelapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy\u003C\/a\u003E. \u003Ci\u003EJournal of Clinical Oncology\u003C\/i\u003E, \u003Ci\u003E39\u003C\/i\u003E(2), 107-115.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Nydegger, A., Novak, U., Kronig, M.-N., Legros, M., Zeerleder, S. S., Banz W\u00e4lti, Y. S., Bacher, V. U., \u0026 Pabst, T. N. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/58114\u0022\u003ETransformed Lymphoma Is Associated with a Favorable Response to CAR-T-Cell Treatment in DLBCL Patients\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E13\u003C\/i\u003E(23).","year":2021,"type":"Journal Article (Original Article)"},{"title":"Jeker, B., Daskalakis, M., Zeerleder, S. S., Pabst, T. N., \u0026 Novak, U. (2021, January). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/66610\u0022\u003ECAR T Cells: Immuntherapie mit grossem Potenzial\u003C\/a\u003E. \u003Ci\u003EOnkologie \u0026 H\u00e4matologie\u003C\/i\u003E, \u003Ci\u003E2021\u003C\/i\u003E, 16-19.","year":2021,"type":"Magazine Article"},{"title":"Zander, T., Pabst, T. N., Sch\u00e4r, S., Aebi, S., Pabst, T., Mey, U., Novak, U., Lerch, E., Rhyner, G., Goede, J., Maniecka, Z., Hayoz, S., Rufer, A., Renner, C., \u0026 Driessen, C. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/116968\u0022\u003EP-227: Alternate day dosing of pomalidomide in patients with refractory\/relapsed multiple myeloma (RRMM): Results of a multicenter, single arm phase 2 trial (SAKK 39\/16 OptiPOM Study)\u003C\/a\u003E. \u003Ci\u003EClinical Lymphoma, Myeloma and Leukemia\u003C\/i\u003E, \u003Ci\u003E21\u003C\/i\u003E(Suppl. 2), S165.","year":2021,"type":"Journal Article (Further Contribution)"},{"title":"Brechb\u00fchl, S., Bacher, V. U., Jeker, B., \u0026 Pabst, T. N. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/39917\u0022\u003EReal-World Outcome in the pre-CAR-T Era of Myeloma Patients Qualifying for CAR-T Cell Therapy\u003C\/a\u003E. \u003Ci\u003EMediterranean Journal of Hematology and Infectious Diseases\u003C\/i\u003E, \u003Ci\u003E13\u003C\/i\u003E(1), e2021012.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Moccia, A. A., Taverna, C., Sch\u00e4r, S., Vanazzi, A., Rondeau, S., Hitz, F., Mingrone, W., Pabst, T. N., Cevreska, L., Del Giglio, A., Raats, J., Rauch, D., Vorobiof, D. A., Lohri, A., Ruegsegger, C., Biaggi Rudolf, C., Rusterholz, C., Hayoz, S., Ghielmini, M., \u0026 Zucca, E. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/55872\u0022\u003EProlonged rituximab maintenance in follicular lymphoma patients: long-term results of the SAKK 35\/03 randomized trial\u003C\/a\u003E. \u003Ci\u003EBlood Advances\u003C\/i\u003E, \u003Ci\u003E4\u003C\/i\u003E(23), 5951-5957.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Averbuch, D., Tridello, G., Hoek, J., Mikulska, M., Pabst, T. N., Ya\u0148ez San Segundo, L., Akan, H., \u00d6z\u00e7elik, T., Donnini, I., Klyasova, G., Botelho de Sousa, A., Zuckerman, T., Tecchio, C., de la Camara, R., Aki, S. Z., Ljungman, P., G\u00fclbas, Z., Nicolas-Virelizier, E., Calore, E., \u2026 Cesaro, S. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/38546\u0022\u003EIntercontinental study on pre-engraftment and post-engraftment Gram-negative rods bacteremia in hematopoietic stem cell transplantation patients: Risk factors and association with mortality\u003C\/a\u003E. \u003Ci\u003EJournal of Infection\u003C\/i\u003E, \u003Ci\u003E81\u003C\/i\u003E(6), 882-894.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Schwotzer, R., Flammer, A. J., Gerull, S., Pabst, T. N., Arosio, P., Averaimo, M., Bacher, V. U., Bode, P., Cavalli, A., Concoluci, A., Dirnhofer, S., Djerbi, N., Dobner, S., Fehr, T., Garofalo, M., Gaspert, A., Heimgartner, R., H\u00fcbers, A., Jung, H. H., \u2026 Gerber, B. (2020). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/38734\u0022\u003EExpert recommendation from the Swiss Amyloidosis Network (SAN) for systemic AL-amyloidosis.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003ESwiss Medical Weekly\u003C\/i\u003E, \u003Ci\u003E150\u003C\/i\u003E(w20364), w20364.","year":2020,"type":"Journal Article (Review)"},{"title":"Jeker, B., Farag, S. A. I., Mansouri Taleghani, B., Novak, U., Mueller, B. U., Li, Q., Betticher, D., Luethi, J.-M., Farese, S., Ruefer, A., Bacher, V. U., \u0026 Pabst, T. N. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/54866\u0022\u003EA randomized evaluation of vinorelbine versus gemcitabine chemotherapy mobilization of stem cells in myeloma patients\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E55\u003C\/i\u003E(10), 2047-2051.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Flach, J., Shumilov, E., Wiedemann, G., Porret, N., Shakhanova, I., B\u00fcrki, S., Legros, M., Joncourt, R., Pabst, T. N., \u0026 Bacher, V. U. (2020). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/36134\u0022\u003EClinical potential of introducing next-generation sequencing in patients at relapse of acute myeloid leukemia.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EHematological Oncology\u003C\/i\u003E, \u003Ci\u003E38\u003C\/i\u003E(4), 425-431.","year":2020,"type":"Journal Article (Review)"},{"title":"Waitz, M., Engel, C., Schloesser, R., Rochwalsky, U., Meyer, S., Larsen, A., Hoffmann, P., Zemlin, M., Bohnhorst, B., Peter, C., Hoppenz, M., Pabst, T. N., Zimmer, K.-P., Franz, A. R., Haertel, C., Frieauff, E., Sandk\u00f6tter, J., Masjosthusmann, K., Deindl, P., \u2026 Ehrhardt, H. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/38591\u0022\u003EApplication of two different nasal CPAP levels for the treatment of respiratory distress syndrome in preterm infants-\u0022The OPTTIMMAL-Trial\u0022-Optimizing PEEP To The IMMAture Lungs: study protocol of a randomized controlled trial\u003C\/a\u003E. \u003Ci\u003ETrials\u003C\/i\u003E, \u003Ci\u003E21\u003C\/i\u003E(1), 822.","year":2020,"type":"Journal Article (Further Contribution)"},{"title":"Idle, J. R., Seipel, K., Bacher, V. U., Pabst, T. N., \u0026 Beyo\u011flu, D. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/45079\u0022\u003E(2R,3S)-Dihydroxybutanoic Acid Synthesis as a Novel Metabolic Function of Mutant Isocitrate Dehydrogenase 1 and 2 in Acute Myeloid Leukemia\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E12\u003C\/i\u003E(10).","year":2020,"type":"Journal Article (Original Article)"},{"title":"Eicher, F., Mansouri Taleghani, B., Schild, C., Bacher, V. U., \u0026 Pabst, T. N. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/36420\u0022\u003EReduced survival after autologous stem cell transplantation in myeloma and lymphoma patients with low vitamin D serum levels\u003C\/a\u003E. \u003Ci\u003EHematological Oncology\u003C\/i\u003E, \u003Ci\u003E38\u003C\/i\u003E(4), 523-530.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Huls, G., Chitu, D. A., Pabst, T. N., Klein, S. K., Stussi, G., Griskevicius, L., Valk, P. J. M., Cloos, J., van de Loosdrecht, A. A., Breems, D., van Lammeren-Venema, D., van Zeventer, I., Boersma, R., Jongen-Lavrencic, M., Fehr, M., Hoogendoorn, M., Manz, M. G., S\u00f6hne, M., van Marwijk Kooy, R., \u2026 Ossenkoppele, G. J. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/37697\u0022\u003EIbrutinib added to 10-day decitabine for older patients with AML and higher risk MDS\u003C\/a\u003E. \u003Ci\u003EBlood Advances\u003C\/i\u003E, \u003Ci\u003E4\u003C\/i\u003E(18), 4267-4277.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Colucci, G., Pabst, T. N., Bacher, V. U., Maggioli, C., Zecca, C., \u0026 Gobbi, C. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/37207\u0022\u003EA case of CIDP concurrent with MGUS IgG kappa responsive to autologous stem cell transplantation\u003C\/a\u003E. \u003Ci\u003ENeurology: Neuroimmunology and Neuroinflammation\u003C\/i\u003E, \u003Ci\u003E7\u003C\/i\u003E(6).","year":2020,"type":"Journal Article (Further Contribution)"},{"title":"Riether, C., Pabst, T. N., H\u00f6pner, S., Bacher, V. U., Hinterbrandner, M., Banz W\u00e4lti, Y. S., M\u00fcller, R., Manz, M. G., Gharib, W., Ferreira Francisco, D. M., Bruggmann, R., van Rompaey, L., Moshir, M., Delahaye, T., Gandini, D., Erzeel, E., Hultberg, A., Fung, S., de Haard, H., \u2026 Ochsenbein, A. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/55076\u0022\u003ETargeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents\u003C\/a\u003E. \u003Ci\u003ENature Medicine\u003C\/i\u003E, \u003Ci\u003E26\u003C\/i\u003E(9), 1459-1467.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Benz, R., Arn, K., Andres, M., Pabst, T. N., Baumann, M., Novak, U., Hitz, F., Hess, U., Zenhaeusern, R., Chalandon, Y., Mey, U., Blum, S., Rauch, D., O\u2019Meara Stern, A., Cantoni, N., Bargetzi, M., Bianchi-Papina, E., Rossi, D., Passweg, J., \u2026 Stussi, G. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/55354\u0022\u003EProspective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial\u003C\/a\u003E. \u003Ci\u003EBlood Advances\u003C\/i\u003E, \u003Ci\u003E4\u003C\/i\u003E(15), 3699-3707.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Fagnan, A., Bagger, F. O., Piqu\u00e9-Borr\u00e0s, M.-R., Ignacimouttou, C., Caulier, A., Lopez, C. K., Robert, E., Uzan, B., Gelsi-Boyer, V., Aid, Z., Thirant, C., Moll, U., Tauchmann, S., Kurtovic-Kozaric, A., Maciejewski, J., Dierks, C., Spinelli, O., Salmoiraghi, S., Pabst, T. N., \u2026 Mercher, T. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/36741\u0022\u003EHuman erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E136\u003C\/i\u003E(6), 698-714.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Sula, M., Bacher, V. U., Oppliger Leibundgut, E., Mansouri Taleghani, B., Novak, U., \u0026 Pabst, T. N. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/184146\u0022\u003EExcellent outcome after consolidation with autologous transplantation in patients with core binding factor acute myeloid leukemia\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E55\u003C\/i\u003E(8), 1690-1693.","year":2020,"type":"Journal Article (Further Contribution)"},{"title":"Pabst, T. N., Joncourt, R., Shumilov, E., Heini, A., Wiedemann, G., Legros, M., Seipel, K., Schild, C., Jalowiec, K. A., Mansouri Taleghani, B., Fux, M., Novak, U., Porret, N., Zeerleder, S. S., \u0026 Bacher, V. U. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/36540\u0022\u003EAnalysis of IL-6 serum levels and CAR-T cell specific digital PCR in the context of cytokine release syndrome (CRS)\u003C\/a\u003E. \u003Ci\u003EExperimental Hematology\u003C\/i\u003E, \u003Ci\u003E88\u003C\/i\u003E, 7-14e3.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Orvain, C., Balsat, M., Tavernier, E., Marolleau, J.-P., Pabst, T. N., Chevallier, P., de Gunzburg, N., Cacheux, V., Huguet, F., Chantepie, S., Caillot, D., Chalandon, Y., Frayfer, J., Bonmati, C., Lheritier, V., Ifrah, N., Dombret, H., Boissel, N., \u0026 Hunault-Berger, M. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/36744\u0022\u003EThromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 study\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E136\u003C\/i\u003E(3), 328-338.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Ossenkoppele, G. J., Breems, D. A., Stuessi, G., van Norden, Y., Bargetzi, M., Biemond, B. J., A von dem Borne, P., Chalandon, Y., Cloos, J., Deeren, D., Fehr, M., Gjertsen, B., Graux, C., Huls, G., Janssen, J. J. J. W., Jaspers, A., Jongen-Lavrencic, M., de Jongh, E., Klein, S. K., \u2026 L\u00f6wenberg, B. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/37192\u0022\u003ELenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS\u003C\/a\u003E. \u003Ci\u003ELeukemia\u003C\/i\u003E, \u003Ci\u003E34\u003C\/i\u003E(7), 1751-1759.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Flach, J., Shumilov, E., Joncourt, R., Porret, N., Novak, U., Pabst, T. N., \u0026 Bacher, V. U. (2020). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/36139\u0022\u003ECurrent concepts and future directions for hemato-oncologic diagnostics.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003ECritical Reviews in Oncology, Hematology\u003C\/i\u003E, \u003Ci\u003E151\u003C\/i\u003E, 102977.","year":2020,"type":"Journal Article (Review)"},{"title":"Flach, J., Shumilov, E., Joncourt, R., Porret, N., Tchinda, J., Legros, M., Scarpelli, I., Hewer, E. W., Novak, U., Schoumans, J., Bacher, V. U., \u0026 Pabst, T. N. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/183632\u0022\u003EDetection of rare reciprocal RUNX1 rearrangements by next\u2010generation sequencing (NGS) in acute myeloid leukemia\u003C\/a\u003E. \u003Ci\u003EGenes, Chromosomes \u0026 Cancer\u003C\/i\u003E, \u003Ci\u003E59\u003C\/i\u003E(4), 268-274.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Passweg, J. R., Labopin, M., Christopeit, M., Cornelissen, J., Pabst, T. N., Soci\u00e9, G., Russel, N., Yakoub-Agha, I., Blaise, D., Gedde-Dahl, T., Labussi\u00e8re-Wallet, H., Malladi, R., Forcade, E., Maury, S., Polge, E., Lanza, F., Gorin, N. C., Mohty, M., \u0026 Nagler, A. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/184138\u0022\u003EPost remission consolidation by autologous HCT for AML in CR1, negative implications for subsequent allogeneic HCT in CR2. A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)\u003C\/a\u003E. \u003Ci\u003EBiology of Blood and Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E26\u003C\/i\u003E(4), 659-664.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Heini, A., Hugo, R., Berger, M. D., Novak, U., Bacher, V. U., \u0026 Pabst, T. N. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/183827\u0022\u003EA simple acute phase protein score to predict long-term survival in patients with acute myeloid leukemia\u003C\/a\u003E. \u003Ci\u003EHematological Oncology\u003C\/i\u003E, \u003Ci\u003E38\u003C\/i\u003E(1), 74-81.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Seipel, K., Messerli, C., Wiedemann, G., Bacher, V. U., \u0026 Pabst, T. N. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/45823\u0022\u003EMN1, FOXP1 and hsa-miR-181a-5p as prognostic markers in acute myeloid leukemia patients treated with intensive induction chemotherapy and autologous stem cell transplantation\u003C\/a\u003E. \u003Ci\u003ELeukemia Research\u003C\/i\u003E, \u003Ci\u003E89\u003C\/i\u003E(106296), 106296.","year":2020,"type":"Journal Article (Original Article)"},{"title":"De Santiago de Benito, A., Jeker, B., Gfeller, E., Porret, N., Banz W\u00e4lti, Y. S., Novak, U., Bacher, V. U., \u0026 Pabst, T. N. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/182223\u0022\u003EMolecular minimal residual disease negativity and decreased stem cell mobilization potential predict excellent outcome after autologous transplant in NPM1 mutant acute myeloid leukemia\u003C\/a\u003E. \u003Ci\u003EHaematologica - the Hematology Journal\u003C\/i\u003E, \u003Ci\u003E105\u003C\/i\u003E(1), e9-e12.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Flach, J., Shumilov, E., Porret, N., Shakhanova, I., Legros, M., Kronig, M.-N., Joncourt, R., Bacher, V. U., \u0026 Pabst, T. N. (2020). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/37696\u0022\u003EExperiences with Next-Generation Sequencing in Relapsed Acute Myeloid Leukemia: A Patient Case Series.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EMediterranean Journal of Hematology and Infectious Diseases\u003C\/i\u003E, \u003Ci\u003E12\u003C\/i\u003E(1), e2020068.","year":2020,"type":"Journal Article (Review)"},{"title":"Messikommer, A., Seipel, K., Byrne, S., Valk, P. J. M., Pabst, T. N., \u0026 Luedtke, N. W. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/37747\u0022\u003ERNA Targeting in Acute Myeloid Leukemia\u003C\/a\u003E. \u003Ci\u003EACS Pharmacology \u0026 Translational Science\u003C\/i\u003E, \u003Ci\u003E3\u003C\/i\u003E(6), 1225-1232.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Rindlisbacher, B., Schild, C., Egger, F., Bacher, V. U., Pabst, T. N., Leichtle, A. B., Andres, M., \u0026 S\u00e9dille-Mostafaie, N. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/36138\u0022\u003ESerum Free Light Chain Assay: Shift Toward a Higher \u03ba\/\u03bb Ratio\u003C\/a\u003E. \u003Ci\u003EThe Journal of Applied Laboratory Medicine\u003C\/i\u003E, \u003Ci\u003E5\u003C\/i\u003E(1), 114-125.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Prediletto, I., Farag, S. A. I., Bacher, V. U., Jeker, B., Mansouri Taleghani, B., Bregy, R., Zander, T., Betticher, D., Egger, T., Novak, U., \u0026 Pabst, T. N. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/182024\u0022\u003EHigh incidence of reversible renal toxicity of dose-intensified bendamustine-based high-dose chemotherapy in lymphoma and myeloma patients\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E54\u003C\/i\u003E(12), 1923-1925.","year":2019,"type":"Journal Article (Further Contribution)"},{"title":"Moser, S., Bacher, V. U., Jeker, B., Mansouri Taleghani, B., Betticher, D., Ruefer, A., Egger, T., Novak, U., \u0026 Pabst, T. N. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/182021\u0022\u003EAutologous stem cell transfusions on multiple days in patients with multiple myeloma \u2010 does it matter\u003C\/a\u003E? \u003Ci\u003EHematological Oncology\u003C\/i\u003E, \u003Ci\u003E37\u003C\/i\u003E(5), 649-651.","year":2019,"type":"Journal Article (Further Contribution)"},{"title":"Seipel, K., Schmitter-Schmidt, K. I., Bacher, V. U., \u0026 Pabst, T. N. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/183562\u0022\u003ERationale for a Combination Therapy Consisting of MCL1- and MEK-Inhibitors in Acute Myeloid Leukemia\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E11\u003C\/i\u003E(11).","year":2019,"type":"Journal Article (Original Article)"},{"title":"Shumilov, E., Flach, J., Joncourt, R., Porret, N., Wiedemann, G., Novak, U., Gfeller, E., Jeker, B., Amstutz, U., Pabst, T. N., \u0026 Bacher, V. U. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/182789\u0022\u003EClinical value of molecular MRD monitoring by next-generation sequencing in patients with IDH2 mutated AML\u003C\/a\u003E. \u003Ci\u003ELeukemia \u0026 Lymphoma\u003C\/i\u003E, \u003Ci\u003E60\u003C\/i\u003E(10), 2588-2590.","year":2019,"type":"Journal Article (Further Contribution)"},{"title":"Fassbind, P., Jeker, B., M\u00fcller, B. U., Bacher, V. U., Zimmerli, S., Endrich, O., Gahl, B., Novak, U., \u0026 Pabst, T. N. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/180299\u0022\u003EImproved survival rates of AML patients following admission to the intensive care unit\u003C\/a\u003E. \u003Ci\u003ELeukemia \u0026 Lymphoma\u003C\/i\u003E, \u003Ci\u003E60\u003C\/i\u003E(10), 2423-2431.","year":2019,"type":"Journal Article (Original Article)"},{"title":"Engelbrecht, L., G\u00f6tze, K., Schwamborn, K., M\u00fcller-Thomas, C., Alpermann, T., Bonadies, N., Legros, M., Flach, J., Pabst, T. N., Banz W\u00e4lti, Y. S., \u0026 Bacher, V. U. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/185117\u0022\u003ECorrelation of cytomorphology and histopathology in the diagnostic process of myeloid malignancies\u003C\/a\u003E. \u003Ci\u003EHematology \u0026 Medical Oncology\u003C\/i\u003E.","year":2019,"type":"Journal Article (Original Article)"},{"title":"Angelillo, A., Mansouri Taleghani, B., F\u00f6rger, F., Baerlocher, G. M., Pabst, T. N., P\u00f6llinger, A., Banz W\u00e4lti, Y. S., Geiser, T., Kremer Hovinga Strebel, J. A., \u0026 Rov\u00f3, A. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/193423\u0022\u003EImmunoadsorption and autologous transplantation for life-threatening primary antiphospholipid syndrome\u003C\/a\u003E. \u003Ci\u003EBlood Advances\u003C\/i\u003E, \u003Ci\u003E3\u003C\/i\u003E(17), 2664-2667.","year":2019,"type":"Journal Article (Further Contribution)"},{"title":"Hitz, F., Kraus, M., Pabst, T. N., Hess, D., Besse, L., Silzle, T., Novak, U., Seipel, K., Rondeau, S., St\u00fcdeli, S., Vilei, S. B., Samaras, P., Mey, U., \u0026 Driessen, C. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/182788\u0022\u003ENelfinavir and lenalidomide\/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I\/II Trial (SAKK 39\/10)\u003C\/a\u003E. \u003Ci\u003EBlood Cancer Journal\u003C\/i\u003E, \u003Ci\u003E9\u003C\/i\u003E(9), 70.","year":2019,"type":"Journal Article (Original Article)"},{"title":"Ghilardi, G., Pabst, T. N., Jeker, B., M\u00fcller, R., Cairoli, A., M\u00fcller, A. M. S., Bargetzi, M., Hitz, F., Baldomero, H., Heim, D., Schmidt, A., Rossi, D., Ghielmini, M., Wannesson, L., Lerch, E., Samaras, P., Schanz, U., Passweg, J. R., Stussi, G., \u2026 Gerber, B. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/62555\u0022\u003EMelphalan dose in myeloma patients \u226565 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry study\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E54\u003C\/i\u003E(7), 1029-1037.","year":2019,"type":"Journal Article (Original Article)"},{"title":"Karow, A., Wilhelm, A., Ammann, R., Baerlocher, G. M., Pabst, T. N., Mansouri Taleghani, B., R\u00f6ssler, J. K., \u0026 Leibundgut, K. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/193290\u0022\u003EPeripheral blood progenitor cell collection in pediatric patients optimized by high pre-apheresis count of circulating CD34+ cells and high blood flow\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E54\u003C\/i\u003E(6), 885-893.","year":2019,"type":"Journal Article (Original Article)"},{"title":"Jent, P., Thalmann, L., Pabst, T. N., Droz, S. C., \u0026 Sendi, P. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/64835\u0022\u003EAdjunctive gentamicin did not improve outcome of enterococcal bacteraemia in neutropenic patients: a propensity scored matched study\u003C\/a\u003E. \u003Ci\u003EInfectious Diseases\u003C\/i\u003E, \u003Ci\u003E51\u003C\/i\u003E(6), 409-416.","year":2019,"type":"Journal Article (Original Article)"},{"title":"Zeijlemaker, W., Grob, T., Meijer, R., Hanekamp, D., Kelder, A., Carbaat-Ham, J. C., Oussoren-Brockhoff, Y. J. M., Snel, A. N., Veldhuizen, D., Scholten, W. J., Maertens, J., Breems, D. A., Pabst, T. N., Manz, M. G., van der Velden, V. H. J., Slomp, J., Preijers, F., Cloos, J., van de Loosdrecht, A. A., \u2026 Schuurhuis, G. J. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/62630\u0022\u003ECD34CD38 leukemic stem cell frequency to predict outcome in acute myeloid leukemia\u003C\/a\u003E. \u003Ci\u003ELeukemia\u003C\/i\u003E, \u003Ci\u003E33\u003C\/i\u003E(5), 1102-1112.","year":2019,"type":"Journal Article (Original Article)"},{"title":"Samaras, P., Bargetzi, M., Betticher, D. C., Driessen, C., Duchosal, M. A., Heim, D., Ketterer, N., Lerch, E., Matthes, T., Mey, U., Pabst, T. N., Schmidt, A., Taverna, C., Zander, T., \u0026 Renner, C. (2019). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/182790\u0022\u003EUpdated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003ESwiss Medical Weekly\u003C\/i\u003E, \u003Ci\u003E2019\u003C\/i\u003E(149), 1-8.","year":2019,"type":"Journal Article (Review)"},{"title":"Amsler, I. G., Jeker, B., Mansouri Taleghani, B., Bacher, V. U., Betticher, D., Egger, T., Zander, T., Luethi, J.-M., Novak, U., \u0026 Pabst, T. N. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/62633\u0022\u003EProlonged survival with increasing duration of lenalidomide maintenance after autologous transplant for multiple myeloma\u003C\/a\u003E. \u003Ci\u003ELeukemia \u0026 Lymphoma\u003C\/i\u003E, \u003Ci\u003E60\u003C\/i\u003E(2), 511-514.","year":2019,"type":"Journal Article (Further Contribution)"},{"title":"Shumilov, E., Flach, J., Joncourt, R., Porret, N., Wiedemann, G., Angelillo, A., Tr\u00fcmper, L., Fiedler, G. M., Jeker, B., Amstutz, U., Pabst, T. N., \u0026 Bacher, V. U. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/182022\u0022\u003ECritical evaluation of current molecular MRD strategies including NGS for the management of AML patients with multiple mutations\u003C\/a\u003E. \u003Ci\u003EHematological Oncology\u003C\/i\u003E, \u003Ci\u003E37\u003C\/i\u003E(3), 319-322.","year":2019,"type":"Journal Article (Further Contribution)"},{"title":"Jeker, B., Pabst, T. N., \u0026 Novak, U. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/62914\u0022\u003ECAR-T-Zelltherapie \u2013 eine neue Behandlungsoption\u003C\/a\u003E. \u003Ci\u003EInfo@Onkologie\u003C\/i\u003E, \u003Ci\u003E2019\u003C\/i\u003E(1), 18-20.","year":2019,"type":"Journal Article (Original Article)"},{"title":"Schnell, B. R., Seipel, K., Bacher, V. U., Jeker, B., Mueller, B. U., Banz W\u00e4lti, Y. S., Novak, U., \u0026 Pabst, T. N. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/182796\u0022\u003ERebound Thrombocytosis after Induction Chemotherapy is a Strong Biomarker for Favorable Outcome in AML Patients\u003C\/a\u003E. \u003Ci\u003EHemaSphere\u003C\/i\u003E, \u003Ci\u003E3\u003C\/i\u003E(2), e180.","year":2019,"type":"Journal Article (Original Article)"},{"title":"Shumilov, E., Novak, U., Jeker, B., Mansouri Taleghani, B., Bacher, V. U., \u0026 Pabst, T. N. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/182795\u0022\u003EHematopoietic Stem Cell Mobilization With Plerixafor Is Safe and Effective in Poorly Mobilizing Acute Myeloid Leukemia Patients\u003C\/a\u003E. \u003Ci\u003EHemaSphere\u003C\/i\u003E, \u003Ci\u003E3\u003C\/i\u003E(2), e176.","year":2019,"type":"Journal Article (Further Contribution)"},{"title":"Borchmann, P., Goergen, H., Kobe, C., Lohri, A., Greil, R., Eichenauer, D. A., Zijlstra, J. M., Markova, J., Meissner, J., Feuring-Buske, M., H\u00fcttmann, A., Dierlamm, J., Soekler, M., Beck, H.-J., Willenbacher, W., Ludwig, W.-D., Pabst, T. N., Topp, M. S., Hitz, F., \u2026 Engert, A. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/62624\u0022\u003EPET-guided treatment in patients with advanced-stage Hodgkin\u2019s lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group\u003C\/a\u003E. \u003Ci\u003ELancet\u003C\/i\u003E, \u003Ci\u003E390\u003C\/i\u003E(10114), 2790-2802.","year":2018,"type":"Journal Article (Original Article)"},{"title":"Riether, C., Pabst, T. N., H\u00f6pner, S., Bacher, V. U., Hinterbrandner, M., Banz W\u00e4lti, Y. S., M\u00fcller, R., Manz, M. G., Gharib, W. H., Ferreira Francisco, D. M., Bruggmann, R., Van Rompaey, L., Moshir, M., Delahaye, T., Gandini, D., Erzeel, E., Hultberg, A., Fung, S., De Haard, H., \u2026 Ochsenbein, A. (2018). \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/180990\u0022\u003E2680 Argx-110 Targeting CD70, in Combination with Azacitidine, Shows Favorable Safety Profile and Promising Anti-Leukemia Activity in Newly Diagnosed AML Patients in an Ongoing Phase 1\/2 Clinical Trial\u003C\/a\u003E\u003C\/i\u003E. ASCO 2018. BORIS Portal.","year":2018,"type":"Conference Paper"},{"title":"Mueller, B. U., Seipel, K., \u0026 Pabst, T. N. (2018). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/62632\u0022\u003EMyelodysplastic syndromes and acute myeloid leukemias in the elderly.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EEuropean Journal of Internal Medicine\u003C\/i\u003E, \u003Ci\u003E58\u003C\/i\u003E, 28-32.","year":2018,"type":"Journal Article (Review)"},{"title":"Moor, I., Bacher, V. U., Jeker, B., Mansouri Taleghani, B., Mueller, B. U., Keller, H. P., Betticher, D., Egger, T., Novak, U., \u0026 Pabst, T. N. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/59972\u0022\u003EPeripheral flow-MRD status at the time of autologous stem cell collection predicts outcome in multiple myeloma\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E53\u003C\/i\u003E(12), 1599-1602.","year":2018,"type":"Journal Article (Further Contribution)"},{"title":"Bacher, V. U., Shumilov, E., Flach, J., Porret, N., Joncourt, R., Wiedemann, G., Fiedler, M., Novak, U., Amstutz, U., \u0026 Pabst, T. N. (2018). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/62329\u0022\u003EChallenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EBlood Cancer Journal\u003C\/i\u003E, \u003Ci\u003E8\u003C\/i\u003E(11), 113.","year":2018,"type":"Journal Article (Review)"},{"title":"Driessen, C., M\u00fcller, R., Novak, U., Cantoni, N., Betticher, D., Mach, N., R\u00fcfer, A., Mey, U., Samaras, P., Ribi, K., Besse, L., Besse, A., Berset, C., Rondeau, S., Hawle, H., Hitz, F., Pabst, T. N., \u0026 Zander, T. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/62561\u0022\u003EPromising activity of nelfinavir-bortezomib-dexamethasone in proteasome inhibitor-refractory multiple myeloma\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E132\u003C\/i\u003E(19), 2097-2100.","year":2018,"type":"Journal Article (Further Contribution)"},{"title":"Shumilov, E., Flach, J., Kohlmann, A., Banz W\u00e4lti, Y. S., Bonadies, N., Fiedler, M., Pabst, T. N., \u0026 Bacher, V. U. (2018). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/163931\u0022\u003ECurrent status and trends in the diagnostics of AML and MDS.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EBlood Reviews\u003C\/i\u003E, \u003Ci\u003E32\u003C\/i\u003E(6), 508-519.","year":2018,"type":"Journal Article (Review)"},{"title":"Seipel, K., Marques, M. A. T., Sidler, C., Mueller, B. U., \u0026 Pabst, T. N. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/62573\u0022\u003EMDM2- and FLT3-inhibitors in the treatment of -ITD acute myeloid leukemia, specificity and efficacy of NVP-HDM201 and midostaurin\u003C\/a\u003E. \u003Ci\u003EHaematologica - the Hematology Journal\u003C\/i\u003E, \u003Ci\u003E103\u003C\/i\u003E(11), 1862-1872.","year":2018,"type":"Journal Article (Original Article)"},{"title":"Farag, S. A. I., Jeker, B., Bacher, V. U., Mansouri Taleghani, B., M\u00fcller, B. U., Novak, U., \u0026 Pabst, T. N. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/59977\u0022\u003EDose-intensified bendamustine and melphalan (BenMel) conditioning before second autologous transplantation in myeloma patients\u003C\/a\u003E. \u003Ci\u003EHematological Oncology\u003C\/i\u003E, \u003Ci\u003E36\u003C\/i\u003E(4), 671-678.","year":2018,"type":"Journal Article (Original Article)"},{"title":"Bacher, V. U., Porret, N., Joncourt, R., Sanz, J., Aliu, N., Wiedemann, G., Jeker, B., Banz W\u00e4lti, Y. S., \u0026 Pabst, T. N. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/59974\u0022\u003EPitfalls in the molecular follow up of mutant acute myeloid leukemia\u003C\/a\u003E. \u003Ci\u003EHaematologica - the Hematology Journal\u003C\/i\u003E, \u003Ci\u003E103\u003C\/i\u003E(10), e486-e488.","year":2018,"type":"Journal Article (Further Contribution)"},{"title":"Simonis, A., Fux, M., Nair, G., Mueller, N. J., Haralambieva, E., Pabst, T. N., Pachlopnik Schmid, J., Schmidt, A., Schanz, U., Manz, M. G., \u0026 M\u00fcller, A. M. S. (2018). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/62575\u0022\u003EAllogeneic hematopoietic cell transplantation in patients with GATA2 deficiency-a case report and comprehensive review of the literature.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EAnnals of Hematology\u003C\/i\u003E, \u003Ci\u003E97\u003C\/i\u003E(10), 1961-1973.","year":2018,"type":"Journal Article (Review)"},{"title":"von Tresckow, B., Kreissl, S., Goergen, H., Br\u00f6ckelmann, P. J., Pabst, T. N., Fridrik, M., Rummel, M., Jung, W., Thiemer, J., Sasse, S., B\u00fcrkle, C., Baues, C., Diehl, V., Engert, A., \u0026 Borchmann, P. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/62560\u0022\u003EIntensive treatment strategies in advanced-stage Hodgkin\u2019s lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trials\u003C\/a\u003E. \u003Ci\u003EThe Lancet. Haematology\u003C\/i\u003E, \u003Ci\u003E5\u003C\/i\u003E(10), e462-e473.","year":2018,"type":"Journal Article (Original Article)"},{"title":"Alva, L. C., Bacher, V. U., Seipel, K., Mansouri Taleghani, B., Mueller, B. U., Novak, U., \u0026 Pabst, T. N. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/59979\u0022\u003EIron overload is correlated with impaired autologous stem cell mobilization and survival in acute myeloid leukemia\u003C\/a\u003E. \u003Ci\u003ETransfusion\u003C\/i\u003E, \u003Ci\u003E58\u003C\/i\u003E(10), 2365-2373.","year":2018,"type":"Journal Article (Original Article)"},{"title":"Huguet, F., Chevret, S., Leguay, T., Thomas, X., Boissel, N., Escoffre-Barbe, M., Chevallier, P., Hunault, M., Vey, N., Bonmati, C., Lepretre, S., Marolleau, J.-P., Pabst, T. N., Rousselot, P., Buzyn, A., Cahn, J.-Y., Lh\u00e9ritier, V., B\u00e9n\u00e9, M. C., Asnafi, V., \u2026 Dombret, H. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/62598\u0022\u003EIntensified Therapy of Acute Lymphoblastic Leukemia in Adults: Report of the Randomized GRAALL-2005 Clinical Trial\u003C\/a\u003E. \u003Ci\u003EJournal of Clinical Oncology\u003C\/i\u003E, \u003Ci\u003E36\u003C\/i\u003E(24), 2514-2523.","year":2018,"type":"Journal Article (Original Article)"},{"title":"K\u00f6ffel, R., Wolfmeier, H. A., Larpin, Y.-N., Besan\u00e7on, H., Sch\u00f6nauer, R., Babiichuk, V., Dr\u00fccker, P., Pabst, T. N., Mitchell, T., Babiichuk, E., \u0026 Draeger, A. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/60493\u0022\u003EHost-Derived Microvesicles Carrying Bacterial Pore-Forming Toxins Deliver Signals to Macrophages: A Novel Mechanism of Shaping Immune Responses\u003C\/a\u003E. \u003Ci\u003EFrontiers in Immunology\u003C\/i\u003E, \u003Ci\u003E9\u003C\/i\u003E(1688), 1688.","year":2018,"type":"Journal Article (Original Article)"},{"title":"Gorin, N. C., Labopin, M., Blaise, D., Dumas, P.-Y., Pabst, T. N., Trisolini, S. M., Arcese, W., Houhou, M., Mohty, M., \u0026 Nagler, A. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/62608\u0022\u003EOptimizing the pretransplant regimen for autologous stem cell transplantation in acute myelogenous leukemia: Better outcomes with busulfan and melphalan compared with busulfan and cyclophosphamide in high risk patients autografted in first complete remission: A study from the acute leukemia working party of the EBMT\u003C\/a\u003E. \u003Ci\u003EAmerican Journal of Hematology\u003C\/i\u003E, \u003Ci\u003E93\u003C\/i\u003E(7), 859-866.","year":2018,"type":"Journal Article (Original Article)"},{"title":"G\u00f6ssi, F., Spahn, M., Samaras, P., Beyer, J., Schardt, J., \u0026 Pabst, T. N. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/62616\u0022\u003EResponse to first-line treatment and histology are associated with achieving complete remission after the first salvage high-dose chemotherapy in relapsing germ cell tumor patients\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E53\u003C\/i\u003E(7), 820-825.","year":2018,"type":"Journal Article (Original Article)"},{"title":"D\u2019Alitto, F., Scherz, A., Margini, C., von Tengg-Kobligk, H., Montani, M., Pabst, T. N., \u0026 Berzigotti, A. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/61225\u0022\u003EPortal Hypertension and a Stiff Liver\u003C\/a\u003E. \u003Ci\u003ECureus\u003C\/i\u003E, \u003Ci\u003E10\u003C\/i\u003E(6), e2768.","year":2018,"type":"Journal Article (Further Contribution)"},{"title":"Junge, A., Bacher, V. U., Mueller, B. U., Keller, P., Solenthaler, M., \u0026 Pabst, T. N. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/59971\u0022\u003EAdverse outcome of AML with aberrant CD16 and CD56 NK cell marker expression\u003C\/a\u003E. \u003Ci\u003EHematological Oncology\u003C\/i\u003E.","year":2018,"type":"Journal Article (Original Article)"},{"title":"Shumilov, E., Flach, J., Pabst, T. N., Fiedler, G. M., Angelillo, A., Tr\u00fcmper, L., Joncourt, R., Kohlmann, A., \u0026 Bacher, V. U. (2018). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/59970\u0022\u003EGenetic alterations crossing the borders of distinct hematopoetic lineages and solid tumors: Diagnostic challenges in the era of high-throughput sequencing in hemato-oncology.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003ECritical Reviews in Oncology, Hematology\u003C\/i\u003E, \u003Ci\u003E126\u003C\/i\u003E, 64-79.","year":2018,"type":"Journal Article (Review)"},{"title":"Seipel, K., Marques, M. A. T., Sidler, C., Mueller, B. U., \u0026 Pabst, T. N. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/62603\u0022\u003EThe Cellular p53 Inhibitor MDM2 and the Growth Factor Receptor FLT3 as Biomarkers for Treatment Responses to the MDM2-Inhibitor Idasanutlin and the MEK1 Inhibitor Cobimetinib in Acute Myeloid Leukemia\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E10\u003C\/i\u003E(6).","year":2018,"type":"Journal Article (Original Article)"},{"title":"Bacher, V. U., \u0026 Pabst, T. N. (2018). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/62771\u0022\u003EAktuelle Entwicklungen in der h\u00e4mato-onkologischen Diagnostik\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EJATROS. H\u00e4matologie \u0026 Onkologie\u003C\/i\u003E, \u003Ci\u003E2018\u003C\/i\u003E(5), 46-49.","year":2018,"type":"Journal Article (Review)"},{"title":"G\u00f6ssi, U., Jeker, B., Mansouri Taleghani, B., Bacher, V. U., Novak, U., Betticher, D., Egger, T., Zander, T., \u0026 Pabst, T. N. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/158491\u0022\u003EProlonged survival after second autologous transplantation and lenalidomide maintenance for salvage treatment of myeloma patients at first relapse after prior autograft\u003C\/a\u003E. \u003Ci\u003EHematological Oncology\u003C\/i\u003E, \u003Ci\u003E36\u003C\/i\u003E(2), 436-444.","year":2018,"type":"Journal Article (Original Article)"},{"title":"Jongen-Lavrencic, M., Grob, T., Hanekamp, D., Kavelaars, F. G., Al Hinai, A., Zeilemaker, A., Erpelinck-Verschueren, C. A. J., Gradowska, P. L., Meijer, R., Cloos, J., Biemond, B. J., Graux, C., van Marwijk Kooy, M., Manz, M. G., Pabst, T. N., Passweg, J. R., Havelange, V., Ossenkoppele, G. J., Sanders, M. A., \u2026 Valk, P. J. M. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/62609\u0022\u003EMolecular Minimal Residual Disease in Acute Myeloid Leukemia\u003C\/a\u003E. \u003Ci\u003ENew England Journal of Medicine NEJM\u003C\/i\u003E, \u003Ci\u003E378\u003C\/i\u003E(13), 1189-1199.","year":2018,"type":"Journal Article (Original Article)"},{"title":"Mathew, N. R., Baumgartner, F., Braun, L., O\u2019Sullivan, D., Thomas, S., Waterhouse, M., M\u00fcller, T. A., Hanke, K., Taromi, S., Apostolova, P., Illert, A. L., Melchinger, W., Duquesne, S., Schmitt-Graeff, A., Osswald, L., Yan, K.-L., Weber, A., Tugues, S., Spath, S., \u2026 Zeiser, R. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/62615\u0022\u003ESorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells\u003C\/a\u003E. \u003Ci\u003ENature Medicine\u003C\/i\u003E, \u003Ci\u003E24\u003C\/i\u003E(3), 282-291.","year":2018,"type":"Journal Article (Original Article)"},{"title":"Jeker, B., Novak, U., Mansouri Taleghani, B., Baerlocher, G. M., Seipel, K., Mueller, B. U., Bigler, M., Betticher, D., Luethi, J.-M., Farese, S., Ruefer, A., \u0026 Pabst, T. N. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/193109\u0022\u003ENSAID treatment with meloxicam enhances peripheral stem cell mobilization in myeloma\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E53\u003C\/i\u003E(2), 175-179.","year":2018,"type":"Journal Article (Original Article)"},{"title":"Mueller, B., Seipel, K., Bacher, V. U., \u0026 Pabst, T. N. (2018). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/62353\u0022\u003EAutologous Transplantation for Older Adults with AML\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E10\u003C\/i\u003E(9), 340.","year":2018,"type":"Journal Article (Review)"},{"title":"Passweg, J. R., Baldomero, H., Ansari, M., Baerlocher, G. M., Bargetzi, M., Chalandon, Y., Duchosal, M. A., Gerull, S., G\u00fcng\u00f6r, T., Halter, J. P., Heim, D., Hess, U., Leibundgut, K., Masouridi-Levrat, S., M\u00fcller, A., Nair, G., Pabst, T. N., Renner, C., Schmidt, A., \u2026 Swiss Blood Stem Cell Transplantation Group, S. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/193228\u0022\u003EHaematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997-2016\u003C\/a\u003E. \u003Ci\u003ESwiss Medical Weekly\u003C\/i\u003E, \u003Ci\u003E148\u003C\/i\u003E(w14589), w14589.","year":2018,"type":"Journal Article (Original Article)"},{"title":"Schlenk, R. F., Krauter, J., Raffoux, E., Kreuzer, K.-A., Schaich, M., Noens, L., Pabst, T. N., Vusirikala, M., Bouscary, D., Spencer, A., Candoni, A., Gil, J. S., Berkowitz, N., Weber, H.-J., \u0026 Ottmann, O. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/158308\u0022\u003EPanobinostat monotherapy and combination therapy in patients with acute myeloid leukemia: results from two clinical trials\u003C\/a\u003E. \u003Ci\u003EHaematologica - the Hematology Journal\u003C\/i\u003E, \u003Ci\u003E103\u003C\/i\u003E(1), e25-e28.","year":2018,"type":"Journal Article (Further Contribution)"},{"title":"Gorin, N.-C., Labopin, M., Pabst, T. N., Remenyi, P., Wu, D., Huynh, A., Volin, L., Cahn, J. Y., Yakoub-Agha, I., Mercier, M., Houhou, M., Mohty, M., \u0026 Nagler, A. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/158331\u0022\u003EUnrelated matched versus autologous transplantation in adult patients with good and intermediate risk acute myelogenous leukemia in first molecular remission\u003C\/a\u003E. \u003Ci\u003EAmerican Journal of Hematology\u003C\/i\u003E, \u003Ci\u003E92\u003C\/i\u003E(12), 1318-1323.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Voegeli, M., Rondeau, S., Berardi Vilei, S., Lerch, E., Wannesson, L., Pabst, T. N., Rentschler, J., Bargetzi, M., Jost, L., Ketterer, N., Bischof Delaloye, A., \u0026 Ghielmini, M. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/147392\u0022\u003EY(90) -Ibritumomab tiuxetan (Y(90) -IT) and high-dose melphalan as conditioning regimen before autologous stem cell transplantation for elderly patients with lymphoma in relapse or resistant to chemotherapy: a feasibility trial (SAKK 37\/05)\u003C\/a\u003E. \u003Ci\u003EHematological Oncology\u003C\/i\u003E, \u003Ci\u003E35\u003C\/i\u003E(4), 576-583.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Berger, M. D., Heini, A. D., Seipel, K., Mueller, B., Angelillo, A., \u0026 Pabst, T. N. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/142800\u0022\u003EIncreased fibrinogen levels at diagnosis are associated with adverse outcome in patients with acute myeloid leukemia\u003C\/a\u003E. \u003Ci\u003EHematological Oncology\u003C\/i\u003E, \u003Ci\u003E35\u003C\/i\u003E(4), 789-796.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Averbuch, D., Tridello, G., Hoek, J., Mikulska, M., Akan, H., Yanez San Segundo, L., Pabst, T. N., \u00d6z\u00e7elik, T., Klyasova, G., Donnini, I., Wu, D., G\u00fclbas, Z., Zuckerman, T., Botelho de Sousa, A., Beguin, Y., Xhaard, A., Bachy, E., Ljungman, P., de la Camara, R., \u2026 Cesaro, S. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/158323\u0022\u003EAntimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group\u003C\/a\u003E. \u003Ci\u003EClinical Infectious Diseases\u003C\/i\u003E, \u003Ci\u003E65\u003C\/i\u003E(11), 1819-1828.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Versluis, J., Kalin, B., Zeijlemaker, W., Passweg, J., Graux, C., Manz, M. G., Vekemans, M.-C., Biemond, B. J., Legdeur, M.-C. J. C., Kooy, M. van M., de Weerdt, O., Wijermans, P. W., Hoogendoorn, M., Bargetzi, M. J., Kuball, J., Schouten, H. C., van der Velden, V. H. J., Janssen, J. J. W. M., Pabst, T. N., \u2026 Cornelissen, J. J. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/67638\u0022\u003EGraft-Versus-Leukemia Effect of Allogeneic Stem-Cell Transplantation and Minimal Residual Disease in Patients With Acute Myeloid Leukemia in First Complete Remission\u003C\/a\u003E. \u003Ci\u003EJCO Precision Oncology\u003C\/i\u003E, \u003Ci\u003E1\u003C\/i\u003E, 1-13.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Metzelder, S. K., Schroeder, T., L\u00fcbbert, M., Ditschkowski, M., G\u00f6tze, K., Scholl, S., Meyer, R. G., Dreger, P., Basara, N., Fey, M., Salih, H. R., Finck, A., Pabst, T. N., Giagounidis, A., Kobbe, G., Wollmer, E., Finke, J., Neubauer, A., \u0026 Burchert, A. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/158301\u0022\u003ELong-term survival of sorafenib-treated FLT3-ITD-positive acute myeloid leukaemia patients relapsing\u00a0after allogeneic stem cell transplantation\u003C\/a\u003E. \u003Ci\u003EEuropean Journal of Cancer\u003C\/i\u003E, \u003Ci\u003E86\u003C\/i\u003E, 233-239.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Ribi, K., Rondeau, S., Hitz, F., Mey, U., Enoiu, M., Pabst, T. N., Stathis, A., Fischer, N., \u0026 Clough, K. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/155663\u0022\u003ECancer-specific geriatric assessment and quality of life: important factors in caring for older patients with aggressive B-cell lymphoma\u003C\/a\u003E. \u003Ci\u003ESupportive Care in Cancer\u003C\/i\u003E, \u003Ci\u003E25\u003C\/i\u003E(9), 2833-2842.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Pabst, T. N., Kortz, L., Fiedler, G. M., Ceglarek, U., Idle, J., \u0026 Beyoglu, D. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/157060\u0022\u003EThe plasma lipidome in acute myeloid leukemia at diagnosis in relation to clinical disease features\u003C\/a\u003E. \u003Ci\u003EBBA Clinical\u003C\/i\u003E, \u003Ci\u003E7\u003C\/i\u003E, 105-114.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Blum-Halter, V., Heini, A. D., Novak, U., Mansouri Taleghani, B., Baerlocher, G. M., Leibundgut, K., Seipel, K., Banz W\u00e4lti, Y. S., Bargetzi, M., \u0026 Pabst, T. N. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/193001\u0022\u003EHematopoietic stem cell remobilization with vinorelbine and filgrastim in AML\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E52\u003C\/i\u003E(5), 786-788.","year":2017,"type":"Journal Article (Further Contribution)"},{"title":"Oberson, J., Novak, U., Mansouri Taleghani, B., Baerlocher, G. M., Seipel, K., Mueller, B., Leibundgut, K., Zimmerli, S., \u0026 Pabst, T. N. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/193123\u0022\u003ERevisiting G-CSF Support for Hematologic Recovery after Autologous Transplantation in AML Patients\u003C\/a\u003E. \u003Ci\u003EAnnals of Hematology \u0026 Oncology\u003C\/i\u003E, \u003Ci\u003E4\u003C\/i\u003E(5), 1148.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Meissner, J., Finel, H., Dietrich, S., Boumendil, A., Kanfer, E., Laboure, G., Abecasis, M., Cornelissen, J., Delage, J., Finke, J., Hess, U., Ludwig, H., Mohty, M., Pabst, T. N., Pioltelli, P., Robinson, S., Samaras, P., Montoto, S., \u0026 Dreger, P. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/147774\u0022\u003EAutologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E52\u003C\/i\u003E(4), 650-652.","year":2017,"type":"Journal Article (Original Article)"},{"title":"L\u00f6wenberg, B., Pabst, T. N., Maertens, J., van Norden, Y., Biemond, B. J., Schouten, H. C., Spertini, O., Vellenga, E., Graux, C., Havelange, V., de Greef, G. E., de Weerdt, O., Legdeur, M.-C. J. C., Kuball, J., Kooy, M. van M., Gjertsen, B. T., Jongen-Lavrencic, M., van de Loosdrecht, A. A., van Lammeren-Venema, D., \u2026 Ossenkoppele, G. J. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/158339\u0022\u003ETherapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E129\u003C\/i\u003E(12), 1636-1645.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Gorin, N.-C., Labopin, M., Czerw, T., Pabst, T. N., Blaise, D., Dumas, P.-Y., Nemet, D., Arcese, W., Trisolini, S. M., Wu, D., Huynh, A., Zuckerman, T., Meijer, E., Cagirgan, S., Cornelissen, J., Houhou, M., Polge, E., Mohty, M., \u0026 Nagler, A. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/147386\u0022\u003EAutologous stem cell transplantation for adult acute myelocytic leukemia in first remission-Better outcomes after busulfan and melphalan compared with busulfan and cyclophosphamide: A retrospective study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)\u003C\/a\u003E. \u003Ci\u003ECancer\u003C\/i\u003E, \u003Ci\u003E123\u003C\/i\u003E(5), 824-831.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Baumgartner, A., Bargetzi, M., Bargetzi, A., Zueger, N., Medinger, M., Passweg, J., Schanz, U., Samaras, P., Chalandon, Y., Pichard, C., Limonta, A., Wannesson, L., Pabst, T. N., Duchosal, M. A., Hess, U., Stanga, Z., Mueller, B., \u0026 Schuetz, P. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/158335\u0022\u003ENutritional support practices in hematopoietic stem cell transplantation centers: A nationwide comparison\u003C\/a\u003E. \u003Ci\u003ENutrition\u003C\/i\u003E, \u003Ci\u003E35\u003C\/i\u003E, 43-50.","year":2017,"type":"Journal Article (Original Article)"},{"title":"G\u00f6ssi, F., Spahn, M., Zweifel, M., Panagiotis, S., Mischo, A., Stenner, F., Hess, U., Berthold, D., Bargetzi, M., Schardt, J., \u0026 Pabst, T. N. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/147388\u0022\u003EComparison of three or fewer high-dose chemotherapy cycles as salvage treatment in germ cell tumors in first relapse\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E52\u003C\/i\u003E(2), 334-336.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Riether, C., Sch\u00fcrch, C., B\u00fchrer, E., Hinterbrandner, M., Huguenin, A.-L., H\u00f6pner, S., Zlobec, I., Pabst, T. N., Radpour, R., \u0026 Ochsenbein, A. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/148651\u0022\u003ECD70\/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemia\u003C\/a\u003E. \u003Ci\u003EThe Journal of Experimental Medicine\u003C\/i\u003E, \u003Ci\u003E214\u003C\/i\u003E(2), 359-380.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Stettler, J., Novak, U., Baerlocher, G. M., Seipel, K., Mansouri Taleghani, B., \u0026 Pabst, T. N. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/192836\u0022\u003EAutologous stem cell transplantation in elderly patients with multiple myeloma: evaluation of its safety and efficacy\u003C\/a\u003E. \u003Ci\u003ELeukemia \u0026 Lymphoma\u003C\/i\u003E, \u003Ci\u003E58\u003C\/i\u003E(5), 1076-1083.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Fridle, C., Medinger, M., Wilk, M. C., Seipel, K., Passweg, J., Manz, M. G., \u0026 Pabst, T. N. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/147390\u0022\u003ECladribine, cytarabine and idarubicin (CLA-Ida) salvage chemotherapy in relapsed acute myeloid leukemia (AML)\u003C\/a\u003E. \u003Ci\u003ELeukemia \u0026 Lymphoma\u003C\/i\u003E, \u003Ci\u003E58\u003C\/i\u003E(5), 1068-1075.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Gilli, S., Novak, U., Mansouri Taleghani, B., Baerlocher, G. M., Leibundgut, K., Banz W\u00e4lti, Y. S., Zander, T., Betticher, D., Egger, T., Rauch, D., \u0026 Pabst, T. N. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/192871\u0022\u003EBeEAM conditioning with bendamustine-replacing BCNU before autologous transplantation is safe and effective in lymphoma patients\u003C\/a\u003E. \u003Ci\u003EAnnals of Hematology\u003C\/i\u003E, \u003Ci\u003E96\u003C\/i\u003E(3), 421-429.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Heini, A. D., Berger, M. D., Seipel, K., Mansouri Taleghani, B., Baerlocher, G. M., Leibundgut, K., Banz W\u00e4lti, Y. S., Novak, U., \u0026 Pabst, T. N. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/192835\u0022\u003EConsolidation with autologous stem cell transplantation in first remission is safe and effective in AML patients above 65 years\u003C\/a\u003E. \u003Ci\u003ELeukemia Research\u003C\/i\u003E, \u003Ci\u003E53\u003C\/i\u003E, 28-34.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Versluis, J., In \u2019t Hout, F. E. M., Devillier, R., van Putten, W. L. J., Manz, M. G., Vekemans, M.-C., Legdeur, M.-C., Passweg, J. R., Maertens, J., Kuball, J., Biemond, B. J., Valk, P. J. M., van der Reijden, B. A., Meloni, G., Schouten, H. C., Vellenga, E., Pabst, T. N., Willemze, R., L\u00f6wenberg, B., \u2026 Cornelissen, J. J. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/147393\u0022\u003EComparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio\u003C\/a\u003E. \u003Ci\u003ELeukemia\u003C\/i\u003E, \u003Ci\u003E31\u003C\/i\u003E(1), 26-33.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Steinr\u00fccken, J., Pabst, T. N., Zimmerli, S., \u0026 Marschall, J. (2016). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/143059\u0022\u003ELow impact of urine cultures as a diagnostic tool in patients with neutropenic fever\u003C\/a\u003E. \u003Ci\u003EInfectious Diseases\u003C\/i\u003E, \u003Ci\u003E48\u003C\/i\u003E(11-12), 872-874.","year":2016,"type":"Journal Article (Further Contribution)"},{"title":"Hitz, F., Zucca, E., Pabst, T. N., Fischer, N., Cairoli, A., Samaras, P., Caspar, C. B., Mach, N., Krasniqi, F., Schmidt, A., Rothermundt, C., Enoiu, M., Eckhardt, K., Berardi Vilei, S., Rondeau, S., \u0026 Mey, U. (2016). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/147396\u0022\u003ERituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38\/08\u003C\/a\u003E. \u003Ci\u003EBritish Journal of Haematology\u003C\/i\u003E, \u003Ci\u003E174\u003C\/i\u003E(2), 255-263.","year":2016,"type":"Journal Article (Original Article)"},{"title":"Taverna, C., Martinelli, G., Hitz, F., Mingrone, W., Pabst, T. N., Cevreska, L., Del Giglio, A., Vanazzi, A., Laszlo, D., Raats, J., Rauch, D., Vorobiof, D. A., Lohri, A., Biaggi Rudolf, C., Rondeau, S., Rusterholz, C., Heijnen, I. A. F. M., Zucca, E., \u0026 Ghielmini, M. (2016). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/138984\u0022\u003ERituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35\/03\u003C\/a\u003E. \u003Ci\u003EJournal of Clinical Oncology\u003C\/i\u003E, \u003Ci\u003E34\u003C\/i\u003E(5), 495-500.","year":2016,"type":"Journal Article (Original Article)"},{"title":"Seipel, K., Marques, M. T., Bozzini, M.-A., Meinken, C., Mueller, B. U., \u0026 Pabst, T. N. (2016). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/138988\u0022\u003EInactivation of the p53-KLF4-CEBPA Axis in Acute Myeloid Leukemia\u003C\/a\u003E. \u003Ci\u003EClinical Cancer Research\u003C\/i\u003E, \u003Ci\u003E22\u003C\/i\u003E(3), 746-756.","year":2016,"type":"Journal Article (Original Article)"},{"title":"Berger, M. D., Branger, G., Klaeser, B., Mansouri Taleghani, B., Novak, U., Banz W\u00e4lti, Y. S., M\u00fcller, B. U., \u0026 Pabst, T. N. (2016). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/131437\u0022\u003EZevalin and BEAM (Z-BEAM) versus rituximab and BEAM (R-BEAM) conditioning chemotherapy prior to autologous stem cell transplantation in patients with mantle cell lymphoma\u003C\/a\u003E. \u003Ci\u003EHematological Oncology\u003C\/i\u003E, \u003Ci\u003E34\u003C\/i\u003E(3), 133-139.","year":2016,"type":"Journal Article (Original Article)"},{"title":"Pathak, A., Seipel, K., Pemov, A., Dewan, R., Brown, C., Ravichandran, S., Luke, B. T., Malasky, M., Suman, S., Yeager, M., Cancer GenomicsResearch Laboratory, N. D., Cancer Sequencing Working Group, N. D., Parry, D. M., Gatti, R. A., Caporaso, N. E., Mulvihill, J., Goldin, L. R., Pabst, T. N., McMaster, M. L., \u0026 Stewart, D. R. (2016). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/138983\u0022\u003EWhole-exome sequencing reveals a C-terminal germline variant in CEBPA-associated acute myeloid leukemia: 45-year follow-up of a large family\u003C\/a\u003E. \u003Ci\u003EHaematologica - the Hematology Journal\u003C\/i\u003E, \u003Ci\u003E101\u003C\/i\u003E(7), 846-852.","year":2016,"type":"Journal Article (Original Article)"},{"title":"Driessen, C., Kraus, M., Joerger, M., Rosing, H., Bader, J., Hitz, F., Berset, C., Xyrafas, A., Hawle, H., Berthod, G., Overkleeft, H. S., Sessa, C., Huitema, A., Pabst, T. N., von Moos, R., Hess, D., \u0026 Mey, U. J. M. (2016). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/138986\u0022\u003ETreatment with the HIV protease inhibitor Nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65\/08)\u003C\/a\u003E. \u003Ci\u003EHaematologica - the Hematology Journal\u003C\/i\u003E, \u003Ci\u003E101\u003C\/i\u003E(3), 346-355.","year":2016,"type":"Journal Article (Original Article)"},{"title":"Mueller, B. U., Keller, S., Seipel, K., Mansouri Taleghani, B., Rauch, D., Betticher, D., Egger, T., \u0026 Pabst, T. N. (2015). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/138989\u0022\u003EStem cell mobilization chemotherapy with gemcitabine is effective and safe in myeloma patients with bortezomib-induced neurotoxicity\u003C\/a\u003E. \u003Ci\u003ELeukemia \u0026 Lymphoma\u003C\/i\u003E, \u003Ci\u003E57\u003C\/i\u003E(5), 1122-1129.","year":2015,"type":"Journal Article (Original Article)"},{"title":"Walter, R. B., Othus, M., L\u00f6wenberg, B., Ossenkoppele, G. J., Petersdorf, S. H., Pabst, T. N., Vekemans, M.-C., Appelbaum, F. R., Erba, H. P., \u0026 Estey, E. H. (2015). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/138993\u0022\u003EEmpiric definition of eligibility criteria for clinical trials in relapsed\/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON\/SAKK and SWOG\u003C\/a\u003E. \u003Ci\u003EHaematologica - the Hematology Journal\u003C\/i\u003E, \u003Ci\u003E100\u003C\/i\u003E(10), e409-e411.","year":2015,"type":"Journal Article (Further Contribution)"},{"title":"Versluis, J., Hazenberg, C. L. E., Passweg, J. R., van Putten, W. L. J., Maertens, J., Biemond, B. J., Theobald, M., Graux, C., Kuball, J., Schouten, H. C., Pabst, T. N., L\u00f6wenberg, B., Ossenkoppele, G., Vellenga, E., \u0026 Cornelissen, J. J. (2015). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/138985\u0022\u003EPost-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysis\u003C\/a\u003E. \u003Ci\u003EThe Lancet. Haematology\u003C\/i\u003E, \u003Ci\u003E2\u003C\/i\u003E(10), e427-e436.","year":2015,"type":"Journal Article (Original Article)"},{"title":"Tawana, K., Wang, J., Renneville, A., B\u00f6d\u00f6r, C., Hills, R., Loveday, C., Savic, A., Van Delft, F. W., Treleaven, J., Georgiades, P., Uglow, E., Asou, N., Uike, N., Debeljak, M., Jazbec, J., Ancliff, P., Gale, R., Thomas, X., Mialou, V., \u2026 Fitzgibbon, J. (2015). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/138992\u0022\u003EDisease evolution and outcomes in familial AML with germline CEBPA mutations\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E126\u003C\/i\u003E(10), 1214-1223.","year":2015,"type":"Journal Article (Original Article)"},{"title":"Schardt, J., Keller, M., Seipel, K., \u0026 Pabst, T. N. (2015). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/138990\u0022\u003EFunctional interplay of SP family members and nuclear factor Y is essential for transcriptional activation of the human Calreticulin gene\u003C\/a\u003E. \u003Ci\u003EBiochimica et Biophysica Acta - Gene Regulatory Mechanisms\u003C\/i\u003E, \u003Ci\u003E1849\u003C\/i\u003E(9), 1188-1197.","year":2015,"type":"Journal Article (Original Article)"},{"title":"Mamot, C., Klingbiel, D., Hitz, F., Renner, C., Pabst, T. N., Driessen, C., Mey, U., Pless, M., Bargetzi, M., Krasniqi, F., Gigli, F., Hany, T., Samarin, A., Biaggi, C., Rusterholz, C., Dirnhofer, S., Zucca, E., \u0026 Martinelli, G. (2015). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/138994\u0022\u003EFinal Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38\/07)\u003C\/a\u003E. \u003Ci\u003EJournal of Clinical Oncology\u003C\/i\u003E, \u003Ci\u003E33\u003C\/i\u003E(23), 2523-2529.","year":2015,"type":"Journal Article (Original Article)"},{"title":"Keller, S., Seipel, K., Novak, U., Mueller, B. U., Mansouri Taleghani, B., Leibundgut, K., \u0026 Pabst, T. N. (2015). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/138996\u0022\u003ENeurotoxicity of stem cell mobilization chemotherapy with vinorelbine in myeloma patients after bortezomib treatment\u003C\/a\u003E. \u003Ci\u003ELeukemia Research\u003C\/i\u003E, \u003Ci\u003E39\u003C\/i\u003E(7), 786-792.","year":2015,"type":"Journal Article (Original Article)"},{"title":"Berger, M. D., Branger, G., Leibundgut, K., Baerlocher, G. M., Seipel, K., Mueller, B. U., Gregor, M., Ruefer, A., \u0026 Pabst, T. N. (2015). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/138997\u0022\u003ECD34+ selected versus unselected autologous stem cell transplantation in patients with advanced-stage mantle cell and diffuse large B-cell lymphoma\u003C\/a\u003E. \u003Ci\u003ELeukemia Research\u003C\/i\u003E, \u003Ci\u003E39\u003C\/i\u003E(6), 561-567.","year":2015,"type":"Journal Article (Original Article)"},{"title":"Kamber, C., Zimmerli, S., Suter, F. M., M\u00fcller, B. U., Mansouri Taleghani, B., Betticher, D., Zander, T., \u0026 Pabst, T. N. (2015). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/190188\u0022\u003EVaricella zoster virus reactivation after autologous SCT is a frequent event and associated with favorable outcome in myeloma patients\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E50\u003C\/i\u003E(4), 573-578.","year":2015,"type":"Journal Article (Original Article)"},{"title":"Cornelissen, J. J., Versluis, J., Passweg, J., van Putten, W. L. J., Manz, M. G., Maertens, J., Beverloo, H. B., Valk, P. J. M., van Marwijk Kooy, M., Wijermans, P. W., Schaafsma, M. R., Biemond, B. J., Vekemans, M.-C., Breems, D. A., Verdonck, L. F., Fey, M., Jongen-Lavrencic, M., Janssen, J. J. W. M., Huls, G., \u2026 L\u00f6wenberg, B. (2015). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/129082\u0022\u003EComparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years\u003C\/a\u003E. \u003Ci\u003ELeukemia\u003C\/i\u003E, \u003Ci\u003E29\u003C\/i\u003E(5), 1041-1050.","year":2015,"type":"Journal Article (Original Article)"},{"title":"Samaras, P., Bargetzi, M., Betticher, D. C., Duchosal, M. A., Heim, D., Hess, U., Ketterer, N., Lerch, E., Matthes, T., Mey, U., Pabst, T. N., Taverna, C., Zander, T., \u0026 Renner, C. (2015). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/138995\u0022\u003ECurrent status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland\u003C\/a\u003E. \u003Ci\u003ESwiss Medical Weekly\u003C\/i\u003E, \u003Ci\u003E145\u003C\/i\u003E, w14100.","year":2015,"type":"Journal Article (Original Article)"},{"title":"Wetzel, D., M\u00fcller, B. U., Mansouri Taleghani, B., Baerlocher, G. M., Seipel, K., Leibundgut, K., \u0026 Pabst, T. N. (2015). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/192424\u0022\u003EDelayed Haematological recovery after autologous stem cell transplantation is associated with favourable outcome in acute myeloid leukaemia\u003C\/a\u003E. \u003Ci\u003EBritish Journal of Haematology\u003C\/i\u003E, \u003Ci\u003E168\u003C\/i\u003E(2), 268-273.","year":2015,"type":"Journal Article (Original Article)"},{"title":"Koechli, V., Klaeser, B., Banz W\u00e4lti, Y. S., M\u00fcller, B. U., \u0026 Pabst, T. N. (2015). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/129058\u0022\u003EConsolidation of first remission using radioimmunotherapy with yttrium-90-ibritumomab-tiuxetan in adult patients with Burkitt lymphoma\u003C\/a\u003E. \u003Ci\u003ELeukemia Research\u003C\/i\u003E, \u003Ci\u003E39\u003C\/i\u003E(3), 307-310.","year":2015,"type":"Journal Article (Original Article)"},{"title":"Garg, A. D., Galluzzi, L., Apetoh, L., Baert, T., Birge, R. B., Bravo-San Pedro, J. M., Breckpot, K., Brough, D., Chaurio, R., Cirone, M., Coosemans, A., Coulie, P. G., De Ruysscher, D., Dini, L., de Witte, P., Dudek-Peric, A. M., Faggioni, A., Fucikova, J., Gaipl, U. S., \u2026 Agostinis, P. (2015). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/138987\u0022\u003EMolecular and Translational Classifications of DAMPs in Immunogenic Cell Death\u003C\/a\u003E. \u003Ci\u003EFrontiers in Immunology\u003C\/i\u003E, \u003Ci\u003E6\u003C\/i\u003E(588), 588.","year":2015,"type":"Journal Article (Original Article)"},{"title":"Voermans, N. C., Benveniste, O., Minnema, M. C., Lokhorst, H., Lammens, M., Meersseman, W., Delforge, M., Kuntzer, T., Novy, J., Pabst, T. N., Bouhour, F., Romero, N., Leblond, V., Bergh, P. van den, Vekemans, M.-C., Engelen, B. G. van, \u0026 Eymard, B. (2014). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/129061\u0022\u003ESporadic late-onset nemaline myopathy with MGUS: long-term follow-up after melphalan and SCT\u003C\/a\u003E. \u003Ci\u003ENeurology\u003C\/i\u003E, \u003Ci\u003E83\u003C\/i\u003E(23), 2133-2139.","year":2014,"type":"Journal Article (Original Article)"},{"title":"Morris, C., de Wreede, L., Scholten, M., Brand, R., van Biezen, A., Sureda, A., Dickmeiss, E., Trneny, M., Apperley, J., Chiusolo, P., van Imhoff, G. W., Lenhoff, S., Martinelli, G., Hentrich, M., Pabst, T. N., Onida, F., Quinn, M., Kroger, N., de Witte, T., \u0026 Ruutu, T. (2014). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/129074\u0022\u003EShould the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide\u003C\/a\u003E. \u003Ci\u003ETransfusion\u003C\/i\u003E, \u003Ci\u003E54\u003C\/i\u003E(10), 2514-2522.","year":2014,"type":"Journal Article (Original Article)"},{"title":"Walter, R. B., Othus, M., Burnett, A. K., L\u00f6wenberg, B., Kantarjian, H. M., Ossenkoppele, G. J., Hills, R. K., Ravandi, F., Pabst, T. N., Evans, A., Pierce, S. R., Vekemans, M.-C., Appelbaum, F. R., \u0026 Estey, E. H. (2014). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/129069\u0022\u003EResistance prediction in AML: analysis of 4601 patients from MRC\/NCRI, HOVON\/SAKK, SWOG and MD Anderson Cancer Center\u003C\/a\u003E. \u003Ci\u003ELeukemia\u003C\/i\u003E, \u003Ci\u003E29\u003C\/i\u003E(2), 312-320.","year":2014,"type":"Journal Article (Original Article)"},{"title":"Terwijn, M., Zeijlemaker, W., Kelder, A., Rutten, A. P., Snel, A. N., Scholten, W. J., Pabst, T. N., Verhoef, G., L\u00f6wenberg, B., Zweegman, S., Ossenkoppele, G. J., \u0026 Schuurhuis, G. J. (2014). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/129065\u0022\u003ELeukemic stem cell frequency: a strong biomarker for clinical outcome in acute myeloid leukemia\u003C\/a\u003E. \u003Ci\u003EPLoS ONE\u003C\/i\u003E, \u003Ci\u003E9\u003C\/i\u003E(9), e107587.","year":2014,"type":"Journal Article (Original Article)"},{"title":"Schmid, A., Friess, D., Mansouri Taleghani, B., Keller, P., M\u00fcller, B. U., Baerlocher, G. M., Leibundgut, K., \u0026 Pabst, T. N. (2014). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/192426\u0022\u003ERole of plerixafor in autologous stem cell mobilization with vinorelbine chemotherapy and granulocyte-colony stimulating factor in patients with myeloma: a phase II study (PAV-trial)\u003C\/a\u003E. \u003Ci\u003ELeukemia \u0026 Lymphoma\u003C\/i\u003E, \u003Ci\u003E56\u003C\/i\u003E(3), 608-614.","year":2014,"type":"Journal Article (Original Article)"},{"title":"Jegerlehner, S., Rothenb\u00fchler, S. P., \u0026 Pabst, T. N. (2014). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/129077\u0022\u003EVision impairment at diagnosis of cancer - choroidal metastasis\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EPraxis - Schweizerische Rundschau F\u00fcr Medizin\u003C\/i\u003E, \u003Ci\u003E103\u003C\/i\u003E(11), 641-647.","year":2014,"type":"Journal Article (Review)"},{"title":"Funke, M., Sch\u00e4fer, S., Pabst, T. N., Geiser, T., Pachlopnik Schmid, J., Dahinden, C. A., \u0026 Zimmerli, S. (2014). \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/192475\u0022\u003ENecrotizing mediastinal lymphadenopathy due to disseminated M. abcessus infection recealing MonoMAc Syndrome - a case report\u003C\/a\u003E\u003C\/i\u003E. Annual Meeting of the Swiss Society for Pneumology, Interlaken. BORIS Portal.","year":2014,"type":"Conference Paper"},{"title":"Funke, M., Sch\u00e4fer, S., Pabst, T. N., Geiser, T., Pachlopnik Schmid, J., Dahinden, C. A., \u0026 Zimmerli, S. (2014, May). \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/192474\u0022\u003ENecrotizing mediastinal lymphadenopathy due to disseminated M. abcessus infection revealing MonoMAc Syndrome - a case report\u003C\/a\u003E\u003C\/i\u003E. Annual Meeting of the Swiss Society for Pneumology, Interlaken. BORIS Portal.","year":2014,"type":"Conference Paper (Abstract)"},{"title":"Raschle, J., Banz W\u00e4lti, Y. S., Suter, T., \u0026 Pabst, T. N. (2014). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/129079\u0022\u003EA single-centre cohort of patients with systemic light chain AL-amyloidosis treated with conventional chemotherapy or with high-dose chemotherapy and autologous stem cell transplantation\u003C\/a\u003E. \u003Ci\u003ESwiss Medical Weekly\u003C\/i\u003E, \u003Ci\u003E144\u003C\/i\u003E, w13922.","year":2014,"type":"Journal Article (Original Article)"},{"title":"Berger, M. D., Banz, Y., \u0026 Pabst, T. N. (2013). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/117014\u0022\u003EPitfalls in the diagnosis of intravascular large B-cell lymphoma\u003C\/a\u003E. \u003Ci\u003EEuropean Journal of Haematology\u003C\/i\u003E, \u003Ci\u003E91\u003C\/i\u003E(6), 563-564.","year":2013,"type":"Journal Article (Original Article)"},{"title":"Terwijn, M., van Putten, W. L. J., Kelder, A., van der Velden, V. H. J., Brooimans, R. A., Pabst, T. N., Maertens, J., Boeckx, N., de Greef, G. E., Valk, P. J. M., Preijers, F. W. M. B., Huijgens, P. C., Drager, A. M., Schanz, U., Jongen-Lavrecic, M., Biemond, B. J., Passweg, J. R., van Gelder, M., Wijermans, P., \u2026 Schuurhuis, G. J. (2013). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/117009\u0022\u003EHigh Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON\/SAKK AML 42A Study\u003C\/a\u003E. \u003Ci\u003EJournal of Clinical Oncology\u003C\/i\u003E, \u003Ci\u003E31\u003C\/i\u003E(31), 3889-3897.","year":2013,"type":"Journal Article (Original Article)"},{"title":"Gutbrodt, K. L., Schliemann, C., Giovannoni, L., Frey, K., Pabst, T. N., Klapper, W., Berdel, W. E., \u0026 Neri, D. (2013). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/117011\u0022\u003EAntibody-Based Delivery of Interleukin-2 to Neovasculature Has Potent Activity Against Acute Myeloid Leukemia\u003C\/a\u003E. \u003Ci\u003EScience Translational Medicine\u003C\/i\u003E, \u003Ci\u003E5\u003C\/i\u003E(201), 201ra118.","year":2013,"type":"Journal Article (Original Article)"},{"title":"Schlenk, R. F., Taskesen, E., van Norden, Y., Krauter, J., Ganser, A., Bullinger, L., Gaidzik, V. I., Paschka, P., Corbacioglu, A., Gohring, G., Kundgen, A., Held, G., Gotze, K., Vellenga, E., Kuball, J., Schanz, U., Passweg, J., Pabst, T. N., Maertens, J., \u2026 Lowenberg, B. (2013). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/117013\u0022\u003EThe value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPA\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E122\u003C\/i\u003E(9), 1576-1582.","year":2013,"type":"Journal Article (Original Article)"},{"title":"B\u00fckki, J., Stanga, Z., Buitrago Tellez, F., Duclos, K., Kolev, M., Kr\u00e4henmann, P., Pabst, T. N., Iff, S., \u0026 J\u00fcni, P. (2013). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/113225\u0022\u003EOmega-3 poly-unsaturated fatty acids for the prevention of severe neutropenic enterocolitis in patients with acute myeloid leukemia\u003C\/a\u003E. \u003Ci\u003ENUTRITION AND CANCER-AN INTERNATIONAL JOURNAL\u003C\/i\u003E, \u003Ci\u003E65\u003C\/i\u003E(6), 834-842.","year":2013,"type":"Journal Article (Original Article)"},{"title":"Gr\u00f6schel, S., Schlenk, R. F., Engelmann, J., Rockova, V., Teleanu, V., K\u00fchn, M. W. M., Eiwen, K., Erpelinck, C., Havermans, M., L\u00fcbbert, M., Germing, U., Schmidt-Wolf, I. G. H., Beverloo, H. B., Schuurhuis, G. J., Ossenkoppele, G. J., Schlegelberger, B., Verdonck, L. F., Vellenga, E., Verhoef, G., \u2026 Delwel, R. (2013). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/84345\u0022\u003EDeregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON\/SAKK Cooperative Group\u003C\/a\u003E. \u003Ci\u003EJournal of Clinical Oncology\u003C\/i\u003E, \u003Ci\u003E31\u003C\/i\u003E(1), 95-103.","year":2013,"type":"Journal Article (Original Article)"},{"title":"Neubauer, H., Pabst, T. N., Dick, A., Machann, W., Evangelista, L., Wirth, C., K\u00f6stler, H., Hahn, D., \u0026 Beer, M. (2013). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/84343\u0022\u003ESmall-bowel MRI in children and young adults with Crohn disease: retrospective head-to-head comparison of contrast-enhanced and diffusion-weighted MRI\u003C\/a\u003E. \u003Ci\u003EPediatric Radiology\u003C\/i\u003E, \u003Ci\u003E43\u003C\/i\u003E(1), 103-14.","year":2013,"type":"Journal Article (Original Article)"},{"title":"Wannesson, L., Bargetzi, M., Cairoli, A., Cerutti, A., Heim, D., Hess, U., Lerch, E., Pabst, T. N., Renner, C., Samaras, P., \u0026 Zucca, E. (2013). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/84346\u0022\u003EAutotransplant for Hodgkin lymphoma after failure of upfront BEACOPP escalated (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine and prednisone)\u003C\/a\u003E. \u003Ci\u003ELeukemia \u0026 Lymphoma\u003C\/i\u003E, \u003Ci\u003E54\u003C\/i\u003E(1), 36-40.","year":2013,"type":"Journal Article (Original Article)"},{"title":"Passweg, J. R., Baldomero, H., Bargetzi, M., Bucher, C., Chalandon, Y., Duchosal, M. A., Gratwohl, A., G\u00fcng\u00f6r, T., Hess, U., Leibundgut, K., de Faveri, G. N., Ozsahin, H., Pabst, T. N., Renner, C., Stern, M., Stussi, G., Schanz, U., \u0026 SBST (Swiss Blood Stem Cell Transplantation Group). (2013). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/84342\u0022\u003EHaematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countries\u003C\/a\u003E. \u003Ci\u003ESwiss Medical Weekly\u003C\/i\u003E, \u003Ci\u003E143\u003C\/i\u003E, w13757.","year":2013,"type":"Journal Article (Original Article)"},{"title":"Passweg, J. R., Pabst, T. N., Blum, S., Bargetzi, M., Li, Q., Heim, D., Stussi, G., Gregor, M., Leoncini, L., Meyer-Monard, S., Brauchli, P., Chalandon, Y., \u0026 Swiss Group for Clinical Cancer Research, S. (2013). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/84341\u0022\u003EAzacytidine for acute myeloid leukemia in elderly or frail patients: A phase II trial (SAKK 30\/07)\u003C\/a\u003E. \u003Ci\u003ELeukemia \u0026 Lymphoma\u003C\/i\u003E, \u003Ci\u003E55\u003C\/i\u003E(1), 87-91.","year":2013,"type":"Journal Article (Original Article)"},{"title":"Hitz, F., Fischer, N., Pabst, T. N., Caspar, C., Berthod, G., Eckhardt, K., Berardi Vilei, S., Zucca, E., Mey, U., \u0026 On behalf of Swiss Group for Clinical Cancer Research (SAKK), B. S. (2013). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/84340\u0022\u003ERituximab, bendamustine, and lenalidomide in patients with aggressive B cell lymphoma not eligible for high-dose chemotherapy or anthracycline-based therapy: phase I results of the SAKK 38\/08 trial\u003C\/a\u003E. \u003Ci\u003EAnnals of Hematology\u003C\/i\u003E, \u003Ci\u003E92\u003C\/i\u003E(8), 1033-1040.","year":2013,"type":"Journal Article (Original Article)"},{"title":"Ossenkoppele, G. J., Stussi, G., Maertens, J., van Montfort, K., Biemond, B. J., Breems, D., Ferrant, A., Graux, C., de Greef, G. E., Halkes, C. J. M., Hoogendoorn, M., Hollestein, R. M., Jongen-Lavrencic, M., Levin, M. D., van de Loosdrecht, A. A., van Marwijk Kooij, M., van Norden, Y., Pabst, T. N., Schouten, H. C., \u2026 L\u00f6wenberg, B. (2012). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/84344\u0022\u003EAddition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK)\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E120\u003C\/i\u003E(24), 4706-11.","year":2012,"type":"Journal Article (Original Article)"},{"title":"von Gr\u00fcnigen, I., Raschle, J., R\u00fcsges-Wolter, I., Mansouri Taleghani, B., Mueller, B. U., \u0026 Pabst, T. N. (2012). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/80600\u0022\u003EThe relapse risk of AML patients undergoing autologous transplantation correlates with the stem cell mobilizing potential\u003C\/a\u003E. \u003Ci\u003ELeukemia Research\u003C\/i\u003E, \u003Ci\u003E36\u003C\/i\u003E(11), 1325-9.","year":2012,"type":"Journal Article (Original Article)"},{"title":"Cornelissen, J. J., Breems, D., van Putten, W. L. J., Gratwohl, A. A., Passweg, J. R., Pabst, T. N., Maertens, J., Beverloo, H. B., van Marwijk Kooy, M., Wijermans, P. W., Biemond, B. J., Vellenga, E., Verdonck, L. F., Ossenkoppele, G. J., \u0026 L\u00f6wenberg, B. (2012). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/84347\u0022\u003EComparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categories\u003C\/a\u003E. \u003Ci\u003EJournal of Clinical Oncology\u003C\/i\u003E, \u003Ci\u003E30\u003C\/i\u003E(17), 2140-6.","year":2012,"type":"Journal Article (Original Article)"},{"title":"Mans, S., Banz W\u00e4lti, Y. S., Mueller, B. U., \u0026 Pabst, T. N. (2012). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/82572\u0022\u003EThe angiogenesis inhibitor vasostatin is regulated by neutrophil elastase-dependent cleavage of calreticulin in AML patients\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E120\u003C\/i\u003E(13), 2690-9.","year":2012,"type":"Journal Article (Original Article)"},{"title":"Pabst, T. N., Vellenga, E., van Putten, W., Schouten, H. C., Graux, C., Vekemans, M.-C., Biemond, B., Sonneveld, P., Passweg, J., Verdonck, L., Legdeur, M.-C., Theobald, M., Jacky, E., Bargetzi, M., Maertens, J., Ossenkoppele, G. J., \u0026 L\u00f6wenberg, B. (2012). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/76979\u0022\u003EFavorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose-escalation of cytarabine\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E119\u003C\/i\u003E(23), 5367-73.","year":2012,"type":"Journal Article (Original Article)"},{"title":"Schardt, J. A., Mueller, B. U., \u0026 Pabst, T. N. (2011). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/76984\u0022\u003EActivation of the unfolded protein response in human acute myeloid leukemia\u003C\/a\u003E. \u003Ci\u003EMethods in Enzymology\u003C\/i\u003E, \u003Ci\u003E489\u003C\/i\u003E, 227-243.","year":2011,"type":"Journal Article (Original Article)"},{"title":"Raschle, J., Ratschiller, D., Mans, S., Mueller, B. U., \u0026 Pabst, T. N. (2011). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/76981\u0022\u003EHigh levels of circulating CD34+ cells at autologous stem cell collection are associated with favourable prognosis in multiple myeloma\u003C\/a\u003E. \u003Ci\u003EBritish Journal of Cancer\u003C\/i\u003E, \u003Ci\u003E105\u003C\/i\u003E(7), 970-4.","year":2011,"type":"Journal Article (Original Article)"},{"title":"Fos, J., Pabst, T. N., Petkovic, V., Ratschiller, D., \u0026 Fos Trigas, J. (2011). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/72922\u0022\u003EDeficient CEBPA DNA binding function in normal karyotype AML patients is associated with favorable prognosis\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E117\u003C\/i\u003E(18), 4881-4.","year":2011,"type":"Journal Article (Original Article)"},{"title":"Patterson, A. D., Maurhofer, O., Beyoglu, D., Lanz, C., Krausz, K. W., Pabst, T. N., Gonzalez, F. J., Dufour, J.-F., \u0026 Idle, J. (2011). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/76980\u0022\u003EAberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling\u003C\/a\u003E. \u003Ci\u003ECancer Research\u003C\/i\u003E, \u003Ci\u003E71\u003C\/i\u003E(21), 6590-600.","year":2011,"type":"Journal Article (Original Article)"},{"title":"L\u00f6wenberg, B., Pabst, T. N., Vellenga, E., van Putten, W., Schouten, H. C., Graux, C., Ferrant, A., Sonneveld, P., Biemond, B. J., Gratwohl, A., de Greef, G. E., Verdonck, L. F., Schaafsma, M. R., Gregor, M., Theobald, M., Schanz, U., Maertens, J., \u0026 Ossenkoppele, G. J. (2011). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/76983\u0022\u003ECytarabine dose for acute myeloid leukemia\u003C\/a\u003E. \u003Ci\u003ENew England Journal of Medicine NEJM\u003C\/i\u003E, \u003Ci\u003E364\u003C\/i\u003E(11), 1027-36.","year":2011,"type":"Journal Article (Original Article)"},{"title":"Haefliger, S., Klebig, C., Schaubitzer, K., Schardt, J., Timchenko, N., Mueller, B. U., \u0026 Pabst, T. N. (2011). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/76982\u0022\u003EProtein disulfide isomerase blocks CEBPA translation and is up-regulated during the unfolded protein response in AML\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E117\u003C\/i\u003E(22), 5931-40.","year":2011,"type":"Journal Article (Original Article)"},{"title":"O\u2019Meara, A., Pabst, T. N., Heim, D., Gerull, S., Bucher, C., Halter, J., Arber, C., Rov\u00f2, A., Tichelli, A., Gratwohl, A., \u0026 Stern, M. (2011). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/71826\u0022\u003EHigh-dose melphalan with or without stem cell support before myeloablative allo-SCT for remission induction in patients with advanced relapsed or refractory AML\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E46\u003C\/i\u003E(5), 636-40.","year":2011,"type":"Journal Article (Original Article)"},{"title":"Taverna, C., Bargetzi, M., Betticher, D., Gm\u00fcr, J., Gregor, M., Heim, D., Hess, U., Ketterer, N., Lerch, E., Matthes, T., Mey, U., Pabst, T. N., \u0026 Renner, C. (2010). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/71828\u0022\u003EIntegrating novel agents into multiple myeloma treatment - current status in Switzerland and treatment recommendations\u003C\/a\u003E. \u003Ci\u003ESwiss Medical Weekly\u003C\/i\u003E, \u003Ci\u003E140\u003C\/i\u003E, w13054.","year":2010,"type":"Journal Article (Further Contribution)"},{"title":"Eyholzer, M., Schmid, S., Wilkens, L., M\u00fcller, B. U., \u0026 Pabst, T. N. (2010). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/71827\u0022\u003EThe tumour-suppressive miR-29a\/b1 cluster is regulated by CEBPA and blocked in human AML\u003C\/a\u003E. \u003Ci\u003EBritish Journal of Cancer\u003C\/i\u003E, \u003Ci\u003E103\u003C\/i\u003E(2), 275-84.","year":2010,"type":"Journal Article (Original Article)"},{"title":"Eyholzer, M., Schmid, S., Schardt, J. A., Haefliger, S., M\u00fcller, B. U., \u0026 Pabst, T. N. (2010). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/70898\u0022\u003EComplexity of miR-223 regulation by CEBPA in human AML\u003C\/a\u003E. \u003Ci\u003ELeukemia Research\u003C\/i\u003E, \u003Ci\u003E34\u003C\/i\u003E(5), 672-6.","year":2010,"type":"Journal Article (Original Article)"},{"title":"Eich, H. T., Diehl, V., G\u00f6rgen, H., Pabst, T. N., Markova, J., Debus, J., Ho, A., D\u00f6rken, B., Rank, A., Grosu, A.-L., Wiegel, T., Karstens, J. H., Greil, R., Willich, N., Schmidberger, H., D\u00f6hner, H., Borchmann, P., M\u00fcller-Hermelink, H.-K., M\u00fcller, R.-P., \u0026 Engert, A. (2010). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/71825\u0022\u003EIntensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin\u2019s lymphoma: final analysis of the German Hodgkin Study Group HD11 trial\u003C\/a\u003E. \u003Ci\u003EJournal of Clinical Oncology\u003C\/i\u003E, \u003Ci\u003E28\u003C\/i\u003E(27), 4199-206.","year":2010,"type":"Journal Article (Original Article)"},{"title":"Schardt, J. A., Eyholzer, M., Timchenko, N. A., M\u00fcller, B. U., \u0026 Pabst, T. N. (2010). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/70900\u0022\u003EUnfolded protein response suppresses CEBPA by induction of calreticulin in acute myeloid leukaemia\u003C\/a\u003E. \u003Ci\u003EJournal of Cellular and Molecular Medicine\u003C\/i\u003E, \u003Ci\u003E14\u003C\/i\u003E(6B), 1509-0519.","year":2010,"type":"Journal Article (Original Article)"},{"title":"Bonadies, N., Pabst, T. N., \u0026 M\u00fcller, B. U. (2010). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/70899\u0022\u003EHeterozygous deletion of the PU.1 locus in human AML\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E115\u003C\/i\u003E(2), 331-4.","year":2010,"type":"Journal Article (Original Article)"},{"title":"M\u00fcller, B. U., \u0026 Pabst, T. N. (2010). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/70901\u0022\u003ELineage-specific transcription factor aberrations in AML\u003C\/a\u003E. \u003Ci\u003ECancer Treatment and Research\u003C\/i\u003E, \u003Ci\u003E145\u003C\/i\u003E, 109-125.","year":2010,"type":"Journal Article (Original Article)"},{"title":"Novy, J., Rosselet, A., Spertini, O., Lobrinus, J. A., Pabst, T. N., \u0026 Kuntzer, T. (2010). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/71830\u0022\u003EChemotherapy is successful in sporadic late onset nemaline myopathy (SLONM) with monoclonal gammopathy\u003C\/a\u003E. \u003Ci\u003EMuscle \u0026 Nerve\u003C\/i\u003E, \u003Ci\u003E41\u003C\/i\u003E(2), 286-7.","year":2010,"type":"Journal Article (Further Contribution)"},{"title":"L\u00f6wenberg, B., Beck, J., Graux, C., van Putten, W., Schouten, H. C., Verdonck, L. F., Ferrant, A., Sonneveld, P., Jongen-Lavrencic, M., von Lilienfeld-Toal, M., Biemond, B. J., Vellenga, E., Breems, D., de Muijnck, H., Schaafsma, R., Verhoef, G., D\u00f6hner, H., Gratwohl, A., Pabst, T. N., \u2026 Maertens, J. (2010). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/71829\u0022\u003EGemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E115\u003C\/i\u003E(13), 2586-91.","year":2010,"type":"Journal Article (Original Article)"},{"title":"Bonadies, N., Neururer, C., Steege, A., Vallabhapurapu, S., Pabst, T. N., \u0026 M\u00fcller, B. U. (2010). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/71111\u0022\u003EPU.1 is regulated by NF-kappaB through a novel binding site in a 17 kb upstream enhancer element\u003C\/a\u003E. \u003Ci\u003EOncogene\u003C\/i\u003E, \u003Ci\u003E29\u003C\/i\u003E(7), 1062-72.","year":2010,"type":"Journal Article (Original Article)"},{"title":"L\u00f6wenberg, B., Ossenkoppele, G. J., van Putten, W., Schouten, H. C., Graux, C., Ferrant, A., Sonneveld, P., Maertens, J., Jongen-Lavrencic, M., von Lilienfeld-Toal, M., Biemond, B. J., Vellenga, E., van Marwijk Kooy, M., Verdonck, L. F., Beck, J., D\u00f6hner, H., Gratwohl, A., Pabst, T. N., \u0026 Verhoef, G. (2009). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/104839\u0022\u003EHigh-dose daunorubicin in older patients with acute myeloid leukemia\u003C\/a\u003E. \u003Ci\u003ENew England Journal of Medicine NEJM\u003C\/i\u003E, \u003Ci\u003E361\u003C\/i\u003E(13), 1235-48.","year":2009,"type":"Journal Article (Original Article)"},{"title":"Weininger, M., Lauterbach, B., Knop, S., Pabst, T. N., Kenn, W., Hahn, D., \u0026 Beissert, M. (2009). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/96066\u0022\u003EWhole-body MRI of multiple myeloma: comparison of different MRI sequences in assessment of different growth patterns\u003C\/a\u003E. \u003Ci\u003EEuropean Journal of Radiology\u003C\/i\u003E, \u003Ci\u003E69\u003C\/i\u003E(2), 339-45.","year":2009,"type":"Journal Article (Original Article)"},{"title":"Pabst, T. N., Eyholzer, M., Fos, J., \u0026 M\u00fcller, B. U. (2009). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/104842\u0022\u003EHeterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis\u003C\/a\u003E. \u003Ci\u003EBritish Journal of Cancer\u003C\/i\u003E, \u003Ci\u003E100\u003C\/i\u003E(8), 1343-6.","year":2009,"type":"Journal Article (Original Article)"},{"title":"Pabst, T. N., \u0026 M\u00fcller, B. U. (2009). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/104840\u0022\u003EComplexity of CEBPA dysregulation in human acute myeloid leukemia\u003C\/a\u003E. \u003Ci\u003EClinical Cancer Research\u003C\/i\u003E, \u003Ci\u003E15\u003C\/i\u003E(17), 5303-7.","year":2009,"type":"Journal Article (Further Contribution)"},{"title":"Schardt, J. A., Weber, D., Eyholzer, M., M\u00fcller, B. U., \u0026 Pabst, T. N. (2009). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/104841\u0022\u003EActivation of the unfolded protein response is associated with favorable prognosis in acute myeloid leukemia\u003C\/a\u003E. \u003Ci\u003EClinical Cancer Research\u003C\/i\u003E, \u003Ci\u003E15\u003C\/i\u003E(11), 3834-41.","year":2009,"type":"Journal Article (Original Article)"},{"title":"Kirstetter, P., Schuster, M. B., Bereshchenko, O., Moore, S., Dvinge, H., Kurz, E., Theilgaard-M\u00f6nch, K., M\u00e5nsson, R., Pedersen, T. A., Pabst, T. N., Schrock, E., Porse, B. T., Jacobsen, S. E. W., Bertone, P., Tenen, D. G., \u0026 Nerlov, C. (2008). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/100513\u0022\u003EModeling of C\/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells\u003C\/a\u003E. \u003Ci\u003ECancer Cell\u003C\/i\u003E, \u003Ci\u003E13\u003C\/i\u003E(4), 299-310.","year":2008,"type":"Journal Article (Original Article)"},{"title":"Ad\u00e8s, L., Sanz, M. A., Chevret, S., Montesinos, P., Chevallier, P., Raffoux, E., Vellenga, E., Guerci, A., Pigneux, A., Huguet, F., Rayon, C., Stoppa, A. M., de la Serna, J., Cahn, J.-Y., Meyer-Monard, S., Pabst, T. N., Thomas, X., de Botton, S., Parody, R., \u2026 Fenaux, P. (2008). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/96071\u0022\u003ETreatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E111\u003C\/i\u003E(3), 1078-84.","year":2008,"type":"Journal Article (Original Article)"},{"title":"Pabst, T. N., Eyholzer, M., Haefliger, S., Schardt, J., \u0026 M\u00fcller, B. U. (2008). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/100512\u0022\u003ESomatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia\u003C\/a\u003E. \u003Ci\u003EJournal of Clinical Oncology\u003C\/i\u003E, \u003Ci\u003E26\u003C\/i\u003E(31), 5088-93.","year":2008,"type":"Journal Article (Original Article)"},{"title":"Pabst, T. N., \u0026 M\u00fcller, B. U. (2007). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/96067\u0022\u003ETranscriptional dysregulation during myeloid transformation in AML\u003C\/a\u003E. \u003Ci\u003EOncogene\u003C\/i\u003E, \u003Ci\u003E26\u003C\/i\u003E(47), 6829-37.","year":2007,"type":"Journal Article (Further Contribution)"},{"title":"M\u00fcller, B. U., Pabst, T. N., Fos Trigas, J., Pegiazoglou, I., Fey, M., Asou, N., B\u00fcrgi, U., \u0026 Tenen, D. G. (2006). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/92773\u0022\u003EATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E107\u003C\/i\u003E(8), 3330-8.","year":2006,"type":"Journal Article (Original Article)"},{"title":"M\u00fcller, B. U., B\u00fcrger, A., Solenthaler, M., Garamvoelgyi, E. M., Oppliger Leibundgut, E., Fey, M., \u0026 Pabst, T. N. (2006). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/92775\u0022\u003EPleural tumors as sole primary manifestation of acute promyelocytic leukemia\u003C\/a\u003E. \u003Ci\u003EAnnals of Oncology\u003C\/i\u003E, \u003Ci\u003E17\u003C\/i\u003E(4), 722-3.","year":2006,"type":"Journal Article (Further Contribution)"},{"title":"Mueller, B. U., \u0026 Pabst, T. N. (2006). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/92772\u0022\u003ECutaneous zygomycosis at catheter insertion site in AML-M4Eo\u003C\/a\u003E. \u003Ci\u003EAnnals of Hematology\u003C\/i\u003E, \u003Ci\u003E85\u003C\/i\u003E(3), 194-5.","year":2006,"type":"Journal Article (Further Contribution)"},{"title":"Pabst, T. N., Fontana, S., Groebli, R., Leibundgut, K., Zwicky, C., \u0026 Mansouri Taleghani, B. (2006). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/92769\u0022\u003EProgenitor cell recruitment during individualized high-flow, very-large-volume apheresis for autologous transplantation improves collection efficiency\u003C\/a\u003E. \u003Ci\u003ETransfusion\u003C\/i\u003E, \u003Ci\u003E46\u003C\/i\u003E(8), 1408-16.","year":2006,"type":"Journal Article (Original Article)"},{"title":"Pabst, T. N., Stillner, E., Neuberg, D., Nimer, S., Willman, C. L., List, A. F., Melo, J. V., Tenen, D. G., \u0026 M\u00fcller, B. U. (2006). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/92771\u0022\u003EMutations of the myeloid transcription factor CEBPA are not associated with the blast crisis of chronic myeloid leukaemia\u003C\/a\u003E. \u003Ci\u003EBritish Journal of Haematology\u003C\/i\u003E, \u003Ci\u003E133\u003C\/i\u003E(4), 400-2.","year":2006,"type":"Journal Article (Original Article)"},{"title":"M\u00fcller, B. U., Pabst, T. N., Hauser, P., Gilliland, G., Neuberg, D., \u0026 Tenen, D. G. (2006). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/92770\u0022\u003EMutations of the transcription factor PU.1 are not associated with acute lymphoblastic leukaemia\u003C\/a\u003E. \u003Ci\u003EBritish Journal of Cancer\u003C\/i\u003E, \u003Ci\u003E94\u003C\/i\u003E(12), 1918-20.","year":2006,"type":"Journal Article (Original Article)"},{"title":"M\u00fcller, B. U., \u0026 Pabst, T. N. (2006). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/92774\u0022\u003EC\/EBPalpha and the pathophysiology of acute myeloid leukemia\u003C\/a\u003E. \u003Ci\u003ECurrent Opinion in Hematology\u003C\/i\u003E, \u003Ci\u003E13\u003C\/i\u003E(1), 7-14.","year":2006,"type":"Journal Article (Original Article)"}]}

UCI – Das Tumorzentrum Bern - Navigation

Servicenavigation

Suche

Pabst, Thomas